{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "This notebook is obselete and has been broken into:\n",
    "vt_contra_metadata_filtering\n",
    "vt_contra_text_preprocessing\n",
    "...\n",
    "\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pyarrow.parquet as pq\n",
    "import pandas as pd\n",
    "import glob\n",
    "import json\n",
    "import re\n",
    "import pprint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "pq_files = glob.glob('../resources/v8_preprocessed/*parquet')\n",
    "\n",
    "metadata_df = pd.read_csv('../resources/metadata.csv')\n",
    "\n",
    "pq_vector_files = glob.glob('../resources/v8_vectors/*')\n",
    "pq_text_files = glob.glob('../resources/v8_preprocessed/*')\n",
    "paired_text_vector_files = list(zip(sorted(pq_text_files), sorted(pq_vector_files)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "def extract_sections_and_vectors(text_df, vector_df, uid_list, sections):\n",
    "    \n",
    "    text_df_with_ids = text_df.loc[text_df.cord_uid.isin(uid_list)]\n",
    "    text_df_of_sections = text_df_with_ids.loc[text_df_with_ids.section.isin(sections)]\n",
    "    sentence_dict = text_df_of_sections.groupby('cord_uid')['sentence'].apply(list).to_dict()\n",
    "    \n",
    "    vector_df_with_ids = vector_df.loc[vector_df.cord_uid.isin(uid_list)]\n",
    "    vector_df_of_sections = vector_df_with_ids.loc[vector_df_with_ids.section.isin(sections)]\n",
    "    vector_dict = text_df_of_sections.groupby('cord_uid')['sentence'].apply(list).to_dict()\n",
    "\"\"\"\n",
    "\n",
    "def extract_sections(text_df, uid_list, sections):\n",
    "    \"\"\"\n",
    "    Returns a dict of {paper_id: section: sentences} for specified paper id and specified sections\n",
    "    \"\"\"\n",
    "    \n",
    "    text_df_with_ids = text_df.loc[text_df.cord_uid.isin(uid_list)]\n",
    "    text_df_of_sections = text_df_with_ids.loc[text_df_with_ids.section.isin(sections)]\n",
    "    section_dict = text_df_of_sections.groupby('cord_uid')['sentence'].apply(list).to_dict()\n",
    "\n",
    "    #concatenate sentences\n",
    "    section_concat_sentences_dict = {k: \" \".join(v) for k,v in section_dict.items()}\n",
    "    \n",
    "    return section_concat_sentences_dict\n",
    "\n",
    "def extract_sections_from_pq_files_by_uid(pq_files, uid_list, sections_oi):\n",
    "    \"\"\"\n",
    "    Iterate through v8 preprocessed parquet files, extracting papers by cord_uid and specified sections.\n",
    "    \"\"\"\n",
    "    master_dict = {}\n",
    "      \n",
    "    for pq_file in pq_files:\n",
    "        print(\"Processing %s...\" % pq_file)\n",
    "        text_df = pd.read_parquet(pq_file)\n",
    "        text_df.loc[:, 'sentence'] = text_df.loc[:, 'sentence'].astype(str)\n",
    "        text_df.loc[:, 'section'] = text_df.loc[:, 'section'].astype(str)\n",
    "\n",
    "        for section in sections_oi:\n",
    "            print(\"Extracting %s section...\" % section)\n",
    "            \n",
    "            if section not in master_dict.keys():\n",
    "                master_dict[section] = {}\n",
    "                \n",
    "            tmp_dict = extract_sections(text_df, uid_list, [section])\n",
    "            for k, v in tmp_dict.items():\n",
    "                master_dict[section].setdefault(k, []).append(v)\n",
    "        \n",
    "    return master_dict\n",
    "\n",
    "def extract_paper_section_headers(pq_files, cord_uids=[]):\n",
    "    \"\"\"\n",
    "    Extract all section headers from parquet text files with specified cord uids.\n",
    "    \n",
    "    Return as dictionary {cord_uid : [section headers]}\n",
    "    \"\"\"\n",
    "    cord_uid_section_header_dict = {}\n",
    "    for pq_file in pq_files:\n",
    "        print(\"Processing %s...\" % pq_file)\n",
    "        text_df = pd.read_parquet(pq_file)\n",
    "        \n",
    "        #Filter to cord_uids if specified, else include all\n",
    "        if cord_uids:\n",
    "            text_df = text_df.loc[text_df.cord_uid.isin(cord_uids)]\n",
    "        \n",
    "        section_dict = text_df.groupby('cord_uid')['section'].apply(list).to_dict()\n",
    "        section_dict_unique = {k: list(set(v)) for k,v in section_dict.items()}\n",
    "        \n",
    "        for cord_uid, sections in section_dict_unique.items():\n",
    "            for section in sections:\n",
    "                cord_uid_section_header_dict.setdefault(cord_uid, set([])).add(section)\n",
    "    \n",
    "    return cord_uid_section_header_dict\n",
    "\n",
    "def extract_paper_sections(pq_files, cord_uids=[]):\n",
    "    \"\"\"\n",
    "    Extract all section texts from parquet text files with specified cord uids.\n",
    "    \n",
    "    Return as dictionary {cord_uid : [section texts]}\n",
    "    \"\"\"\n",
    "    cord_uid_section_text_dict = {}\n",
    "    for pq_file in pq_files:\n",
    "        print(\"Processing %s...\" % pq_file)\n",
    "        text_df = pd.read_parquet(pq_file)\n",
    "        \n",
    "        if cord_uids:\n",
    "            text_df = text_df.loc[text_df.cord_uid.isin(cord_uids)]\n",
    "        \n",
    "        uid_text_dict = dict(tuple(text_df.groupby('cord_uid')))\n",
    "        for cord_uid, paper_df in uid_text_dict.items():\n",
    "            if cord_uid not in cord_uid_section_text_dict:\n",
    "                master_dict[cord_uid] = {}\n",
    "                \n",
    "            section_sentences_dict = dict(tuple(paper_df[['section', 'sentence']].groupby('section')))\n",
    "            for section, sentence_df in section_sentences_dict.items():\n",
    "                sentence_df.loc[:, 'sentence'] = sentence_df.sentence.fillna('')\n",
    "                sentences = sentence_df.sentence.tolist()\n",
    "                \n",
    "                current_sentences = cord_uid_section_text_dict[cord_uid].get(section, '')\n",
    "                new_sentences = current_sentences + ' ' + ' '.join(sentences)\n",
    "                cord_uid_section_text_dict[cord_uid][section] = new_sentences\n",
    "                \n",
    "    return cord_uid_section_text_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Covid-19 df length: 4424\n"
     ]
    }
   ],
   "source": [
    "#Load metadata and generate a filtered list of cord_uids for papers containing covid-19 terms in title or abstract\n",
    "\n",
    "metadata_df.loc[:, 'title_abstract'] = metadata_df.loc[:, 'title'].str.lower() + ' ' + metadata_df.loc[:, 'abstract'].str.lower()\n",
    "metadata_df.loc[:, 'title_abstract'] = metadata_df.loc[:, 'title_abstract'].fillna('')\n",
    "\n",
    "#Prior covid19 term list\n",
    "#covid19_df = metadata_df.loc[metadata_df.title_abstract.str.contains('covid-19|sars-cov-2|2019-ncov|sars coronavirus 2|2019 novel coronavirus')]\n",
    "\n",
    "with open('../resources/covid_19_terms_200427.txt') as f:\n",
    "    covid_19_terms = f.read().splitlines()\n",
    "    covid_19_term_pattern = '|'.join([i.lower() for i in covid_19_terms])\n",
    "\n",
    "covid19_df = metadata_df.loc[metadata_df.title_abstract.str.contains(covid_19_term_pattern)]\n",
    "print(\"Covid-19 df length: %d\" % len(covid19_df))\n",
    "\n",
    "covid19_uid_list = covid19_df.cord_uid.tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Covid-19 df filtered to publication dates after 2019-10-01: 4150\n",
      "Papers filtered out by date cutoff:\n",
      "     cord_uid                                                sha source_x  \\\n",
      "12   qj4dh6rg           3ed670f60a7be2e3e2a991ea8af1fdd5fa5e2b2c      PMC   \n",
      "29   fpj5urao  e9c78584c08ba79d735e150eff98297eb57f12dd; cdb2...      PMC   \n",
      "53   ic4d9dhk           72ace5af731fdf4c384e912b074193d13902b7a1      PMC   \n",
      "54   jh9e85c0           d16e1bd4c6cae1bb55dbc695c5e2ba5105a13921      PMC   \n",
      "103  eqiokrub           10e691d6bf9cfc219bb72a2761d37ae5f1677f77      PMC   \n",
      "\n",
      "                                                 title  \\\n",
      "12   Cloaked similarity between HIV-1 and SARS-CoV ...   \n",
      "29   Moderate mutation rate in the SARS coronavirus...   \n",
      "53   Expression profile of immune response genes in...   \n",
      "54   Molecular mechanisms of severe acute respirato...   \n",
      "103  Croup Is Associated with the Novel Coronavirus...   \n",
      "\n",
      "                              doi       pmcid   pubmed_id license  \\\n",
      "12         10.1186/1471-2180-3-20   PMC222911  14499001.0   no-cc   \n",
      "29         10.1186/1471-2148-4-21   PMC446188  15222897.0   no-cc   \n",
      "53          10.1186/1471-2172-6-2   PMC546205  15655079.0   cc-by   \n",
      "54          10.1186/1465-9921-6-8   PMC548145  15661082.0   cc-by   \n",
      "103  10.1371/journal.pmed.0020240  PMC1188248  16104827.0   cc-by   \n",
      "\n",
      "                                              abstract publish_time  \\\n",
      "12   BACKGROUND: Severe acute respiratory syndrome ...   2003-09-21   \n",
      "29   BACKGROUND: The outbreak of severe acute respi...   2004-06-28   \n",
      "53   BACKGROUND: Severe acute respiratory syndrome ...   2005-01-18   \n",
      "54   Severe acute respiratory syndrome (SARS) is a ...   2005-01-20   \n",
      "103  BACKGROUND: The clinical relevance of infectio...   2005-08-23   \n",
      "\n",
      "                                               authors        journal  \\\n",
      "12                     Kliger, Yossef; Levanon, Erez Y  BMC Microbiol   \n",
      "29   Zhao, Zhongming; Li, Haipeng; Wu, Xiaozhuang; ...  BMC Evol Biol   \n",
      "53   Reghunathan, Renji; Jayapal, Manikandan; Hsu, ...    BMC Immunol   \n",
      "54   Groneberg, David A; Hilgenfeld, Rolf; Zabel, P...     Respir Res   \n",
      "103  van der Hoek, Lia; Sure, Klaus; Ihorst, Gabrie...       PLoS Med   \n",
      "\n",
      "     Microsoft Academic Paper ID WHO #Covidence  has_pdf_parse  \\\n",
      "12                           NaN            NaN           True   \n",
      "29                           NaN            NaN           True   \n",
      "53                           NaN            NaN           True   \n",
      "54                           NaN            NaN           True   \n",
      "103                          NaN            NaN           True   \n",
      "\n",
      "     has_pmc_xml_parse   full_text_file  \\\n",
      "12                True   custom_license   \n",
      "29                True   custom_license   \n",
      "53                True  comm_use_subset   \n",
      "54                True  comm_use_subset   \n",
      "103               True  comm_use_subset   \n",
      "\n",
      "                                                   url  \\\n",
      "12   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2...   \n",
      "29   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4...   \n",
      "53   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...   \n",
      "54   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5...   \n",
      "103  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1...   \n",
      "\n",
      "                                        title_abstract  \n",
      "12   cloaked similarity between hiv-1 and sars-cov ...  \n",
      "29   moderate mutation rate in the sars coronavirus...  \n",
      "53   expression profile of immune response genes in...  \n",
      "54   molecular mechanisms of severe acute respirato...  \n",
      "103  croup is associated with the novel coronavirus...  \n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "Covid-19 was identified in December 2019.  Papers published before this point are unlikely to be relevant.\n",
    "\n",
    "Filtering to papers published after 10-01-2019 to allow for papers before official identification.\n",
    "\"\"\"\n",
    "\n",
    "covid19_date_filtered_df = covid19_df.loc[covid19_df['publish_time'] > '2019-10-01']\n",
    "print(\"Covid-19 df filtered to publication dates after 2019-10-01: %d\" % len(covid19_date_filtered_df))\n",
    "\n",
    "date_incl_cord_uids = set(covid19_date_filtered_df.cord_uid.tolist())\n",
    "date_excl_uids = set(covid19_uid_list) - set(date_incl_cord_uids)\n",
    "\n",
    "print(\"Papers filtered out by date cutoff:\")\n",
    "pprint.pprint(covid19_df.loc[covid19_df.cord_uid.isin(date_excl_uids)].head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing resources/v8_preprocessed/v8processedText1.parquet...\n",
      "Processing resources/v8_preprocessed/v8processedText4.parquet...\n",
      "Processing resources/v8_preprocessed/v8processedText8.parquet...\n",
      "Processing resources/v8_preprocessed/v8processedText10.parquet...\n",
      "Processing resources/v8_preprocessed/v8processedText3.parquet...\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-13-70d2d0380686>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0muid_section_headers_dict\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mextract_paper_section_headers\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpq_files\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mdate_incl_cord_uids\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;32m<ipython-input-12-44af2b4ff6d6>\u001b[0m in \u001b[0;36mextract_paper_section_headers\u001b[0;34m(pq_files, cord_uids)\u001b[0m\n\u001b[1;32m     58\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mpq_file\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mpq_files\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     59\u001b[0m         \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"Processing %s...\"\u001b[0m \u001b[0;34m%\u001b[0m \u001b[0mpq_file\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 60\u001b[0;31m         \u001b[0mtext_df\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mpd\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mread_parquet\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpq_file\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     61\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     62\u001b[0m         \u001b[0;31m#Filter to cord_uids if specified, else include all\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/anaconda3/lib/python3.7/site-packages/pandas/io/parquet.py\u001b[0m in \u001b[0;36mread_parquet\u001b[0;34m(path, engine, columns, **kwargs)\u001b[0m\n\u001b[1;32m    294\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    295\u001b[0m     \u001b[0mimpl\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mget_engine\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mengine\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 296\u001b[0;31m     \u001b[0;32mreturn\u001b[0m \u001b[0mimpl\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mread\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcolumns\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mcolumns\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;32m~/anaconda3/lib/python3.7/site-packages/pandas/io/parquet.py\u001b[0m in \u001b[0;36mread\u001b[0;34m(self, path, columns, **kwargs)\u001b[0m\n\u001b[1;32m    123\u001b[0m         \u001b[0mkwargs\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m\"use_pandas_metadata\"\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mTrue\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    124\u001b[0m         result = self.api.parquet.read_table(\n\u001b[0;32m--> 125\u001b[0;31m             \u001b[0mpath\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcolumns\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mcolumns\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    126\u001b[0m         ).to_pandas()\n\u001b[1;32m    127\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mshould_close\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/anaconda3/lib/python3.7/site-packages/pyarrow/array.pxi\u001b[0m in \u001b[0;36mpyarrow.lib._PandasConvertible.to_pandas\u001b[0;34m()\u001b[0m\n",
      "\u001b[0;32m~/anaconda3/lib/python3.7/site-packages/pyarrow/table.pxi\u001b[0m in \u001b[0;36mpyarrow.lib.Table._to_pandas\u001b[0;34m()\u001b[0m\n",
      "\u001b[0;32m~/anaconda3/lib/python3.7/site-packages/pyarrow/pandas_compat.py\u001b[0m in \u001b[0;36mtable_to_blockmanager\u001b[0;34m(options, table, categories, ignore_metadata)\u001b[0m\n\u001b[1;32m    702\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    703\u001b[0m     \u001b[0m_check_data_column_metadata_consistency\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mall_columns\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 704\u001b[0;31m     \u001b[0mblocks\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0m_table_to_blocks\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0moptions\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtable\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcategories\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    705\u001b[0m     \u001b[0mcolumns\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0m_deserialize_column_index\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtable\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mall_columns\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcolumn_indexes\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    706\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/anaconda3/lib/python3.7/site-packages/pyarrow/pandas_compat.py\u001b[0m in \u001b[0;36m_table_to_blocks\u001b[0;34m(options, block_table, categories)\u001b[0m\n\u001b[1;32m    974\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    975\u001b[0m     \u001b[0;31m# Convert an arrow table to Block from the internal pandas API\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 976\u001b[0;31m     \u001b[0mresult\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mpa\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlib\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtable_to_blocks\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0moptions\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mblock_table\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcategories\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    977\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    978\u001b[0m     \u001b[0;31m# Defined above\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "uid_section_headers_dict = extract_paper_section_headers(pq_files, date_incl_cord_uids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 147,
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import defaultdict\n",
    "import re\n",
    "\n",
    "\n",
    "\"\"\"\n",
    "Identify the list of UIDs containing each unique section header and also count them.\n",
    "\"\"\"\n",
    "\n",
    "section_uids_dict = defaultdict(set)\n",
    "section_counts_dict = defaultdict(int)\n",
    "\n",
    "for uid, sections in uid_section_headers_dict.items():\n",
    "    for section in sections:\n",
    "        section_uids_dict[section].add(uid)\n",
    "        section_counts_dict[section] += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('covid19_paper_section_header_freq_200427.txt', 'w') as f:\n",
    "    for i in sorted(section_counts_dict.items(), key=lambda k_v: k_v[1], reverse=True):\n",
    "        f.write('%s\\t%s\\n' % (i[0], i[1]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing resources/v8_preprocessed/v8processedText1.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText4.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText8.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText10.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText3.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText0.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText12.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText15.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText2.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText6.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText19.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText18.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText11.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText13.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText5.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText7.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText17.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText16.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText14.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n",
      "Processing resources/v8_preprocessed/v8processedText9.parquet...\n",
      "Extracting title section...\n",
      "Extracting abstract section...\n"
     ]
    }
   ],
   "source": [
    "sect_dict = extract_sections_from_pq_files_by_uid(pq_files, covid19_uid_list, ['title', 'abstract'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {},
   "outputs": [],
   "source": [
    "covid19_df.to_csv('../output/vt_contra_v9_covid19_metadata_200427.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of cord_uids in current version: 57366\n",
      "Number of unique cord_uids in current version: 57332\n"
     ]
    }
   ],
   "source": [
    "#Generate a mapping of cord_uids to text files to facilitate extraction\n",
    "\n",
    "all_cord_uids = metadata_df.cord_uid.tolist()\n",
    "\n",
    "print(\"Number of cord_uids in current version: %d\" % len(all_cord_uids))\n",
    "print(\"Number of unique cord_uids in current version: %d\" % len(set(all_cord_uids)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cord_uid</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_pdf_parse</th>\n",
       "      <th>has_pmc_xml_parse</th>\n",
       "      <th>full_text_file</th>\n",
       "      <th>url</th>\n",
       "      <th>title_abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>29489</td>\n",
       "      <td>0klupmep</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Infectious disease surveillance update</td>\n",
       "      <td>10.1016/s1473-3099(19)30075-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30833065.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-03-31</td>\n",
       "      <td>Zwizwai, Ruth</td>\n",
       "      <td>The Lancet Infectious Diseases</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/s1473-3099(19)30075-1</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>16421</td>\n",
       "      <td>0klupmep</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Infectious disease surveillance update</td>\n",
       "      <td>10.1016/s1473-3099(19)30075-1</td>\n",
       "      <td>PMC7129894</td>\n",
       "      <td>30833064.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-02-27</td>\n",
       "      <td>Zwizwai, Ruth</td>\n",
       "      <td>Lancet Infect Dis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>16419</td>\n",
       "      <td>0z5wacxs</td>\n",
       "      <td>7e787fd2ae5b544add6281d3d40ad322de26aa17</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Transportation capacity for patients with high...</td>\n",
       "      <td>10.1111/1469-0691.12290</td>\n",
       "      <td>PMC7128608</td>\n",
       "      <td>25636943.0</td>\n",
       "      <td>no-cc</td>\n",
       "      <td>Highly infectious diseases (HIDs) are defined ...</td>\n",
       "      <td>2015-06-22</td>\n",
       "      <td>Schilling, S.; Maltezou, H.C.; Fusco, F.M.; De...</td>\n",
       "      <td>Clin Microbiol Infect</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7...</td>\n",
       "      <td>transportation capacity for patients with high...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>29293</td>\n",
       "      <td>0z5wacxs</td>\n",
       "      <td>7e787fd2ae5b544add6281d3d40ad322de26aa17</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Transportation capacity for patients with high...</td>\n",
       "      <td>10.1111/1469-0691.12290</td>\n",
       "      <td>NaN</td>\n",
       "      <td>24750421.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Highly infectious diseases (HIDs) are...</td>\n",
       "      <td>2019-04-30</td>\n",
       "      <td>Schilling, S.; Maltezou, H.C.; Fusco, F.M.; De...</td>\n",
       "      <td>Clinical Microbiology and Infection</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1111/1469-0691.12290</td>\n",
       "      <td>transportation capacity for patients with high...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>28740</td>\n",
       "      <td>21htepa1</td>\n",
       "      <td>a25e212b03cc65c44dcc336775b101934e30f041</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Panspermia—true or false?</td>\n",
       "      <td>10.1016/s0140-6736(03)14040-8</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12907025.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2003-08-02</td>\n",
       "      <td>de Leon, Samuel Ponce; Lazcano, Antonio</td>\n",
       "      <td>The Lancet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/s0140-6736(03)14040-8</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>28771</td>\n",
       "      <td>vp5358rr</td>\n",
       "      <td>f3eefad19d628cbe1fc0d65a6322a60d6cc5a3ab</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>PARENTAL ORIGIN OF CHROMOSOME 15 DELETION IN P...</td>\n",
       "      <td>10.1016/s0140-6736(83)92745-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6134086.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983-06-04</td>\n",
       "      <td>Butler, MerlinG.; Palmer, CatherineG.</td>\n",
       "      <td>The Lancet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/s0140-6736(83)92745-9</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>15934</td>\n",
       "      <td>vqbreyna</td>\n",
       "      <td>2513ddf57215cb9297e05db838156d8856c8d6a5</td>\n",
       "      <td>PMC</td>\n",
       "      <td>COVID-19, A Clinical Syndrome Manifesting as H...</td>\n",
       "      <td>10.3947/ic.2020.52.1.110</td>\n",
       "      <td>PMC7113449</td>\n",
       "      <td>32153144.0</td>\n",
       "      <td>cc-by-nc</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-03-10</td>\n",
       "      <td>Song, Young Goo; Shin, Hyoung-Shik</td>\n",
       "      <td>Infect Chemother</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>noncomm_use_subset</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>41120</td>\n",
       "      <td>vqbreyna</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WHO</td>\n",
       "      <td>COVID-19, A Clinical Syndrome Manifesting as H...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>32153144.0</td>\n",
       "      <td>unk</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Song, Young Goo; Shin, Hyoung Shik</td>\n",
       "      <td>Infect Chemother</td>\n",
       "      <td>NaN</td>\n",
       "      <td>#6103</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pubmed/32153144/</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>28439</td>\n",
       "      <td>xjpev4jw</td>\n",
       "      <td>c05522c7132d3162d433c02ade1fc80604625a4f</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Virus-Specific Antibody, in the Absence of T C...</td>\n",
       "      <td>10.1016/s0002-9440(10)62301-2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15743792.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Mice infected with mouse hepatitis virus strai...</td>\n",
       "      <td>2005-03-31</td>\n",
       "      <td>Kim, Taeg S.; Perlman, Stanley</td>\n",
       "      <td>The American Journal of Pathology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "      <td>https://doi.org/10.1016/s0002-9440(10)62301-2</td>\n",
       "      <td>virus-specific antibody, in the absence of t c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>38895</td>\n",
       "      <td>xjpev4jw</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PMC</td>\n",
       "      <td>Virus-Specific Antibody, in the Absence of T C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PMC1602352</td>\n",
       "      <td>15743792.0</td>\n",
       "      <td>unk</td>\n",
       "      <td>Mice infected with mouse hepatitis virus strai...</td>\n",
       "      <td>2005-03-23</td>\n",
       "      <td>Kim, Taeg S.; Perlman, Stanley</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1...</td>\n",
       "      <td>virus-specific antibody, in the absence of t c...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>68 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       cord_uid                                       sha  source_x  \\\n",
       "29489  0klupmep                                       NaN  Elsevier   \n",
       "16421  0klupmep                                       NaN       PMC   \n",
       "16419  0z5wacxs  7e787fd2ae5b544add6281d3d40ad322de26aa17       PMC   \n",
       "29293  0z5wacxs  7e787fd2ae5b544add6281d3d40ad322de26aa17  Elsevier   \n",
       "28740  21htepa1  a25e212b03cc65c44dcc336775b101934e30f041  Elsevier   \n",
       "...         ...                                       ...       ...   \n",
       "28771  vp5358rr  f3eefad19d628cbe1fc0d65a6322a60d6cc5a3ab  Elsevier   \n",
       "15934  vqbreyna  2513ddf57215cb9297e05db838156d8856c8d6a5       PMC   \n",
       "41120  vqbreyna                                       NaN       WHO   \n",
       "28439  xjpev4jw  c05522c7132d3162d433c02ade1fc80604625a4f  Elsevier   \n",
       "38895  xjpev4jw                                       NaN       PMC   \n",
       "\n",
       "                                                   title  \\\n",
       "29489             Infectious disease surveillance update   \n",
       "16421             Infectious disease surveillance update   \n",
       "16419  Transportation capacity for patients with high...   \n",
       "29293  Transportation capacity for patients with high...   \n",
       "28740                          Panspermia—true or false?   \n",
       "...                                                  ...   \n",
       "28771  PARENTAL ORIGIN OF CHROMOSOME 15 DELETION IN P...   \n",
       "15934  COVID-19, A Clinical Syndrome Manifesting as H...   \n",
       "41120  COVID-19, A Clinical Syndrome Manifesting as H...   \n",
       "28439  Virus-Specific Antibody, in the Absence of T C...   \n",
       "38895  Virus-Specific Antibody, in the Absence of T C...   \n",
       "\n",
       "                                 doi       pmcid   pubmed_id    license  \\\n",
       "29489  10.1016/s1473-3099(19)30075-1         NaN  30833065.0  els-covid   \n",
       "16421  10.1016/s1473-3099(19)30075-1  PMC7129894  30833064.0      no-cc   \n",
       "16419        10.1111/1469-0691.12290  PMC7128608  25636943.0      no-cc   \n",
       "29293        10.1111/1469-0691.12290         NaN  24750421.0  els-covid   \n",
       "28740  10.1016/s0140-6736(03)14040-8         NaN  12907025.0  els-covid   \n",
       "...                              ...         ...         ...        ...   \n",
       "28771  10.1016/s0140-6736(83)92745-9         NaN   6134086.0  els-covid   \n",
       "15934       10.3947/ic.2020.52.1.110  PMC7113449  32153144.0   cc-by-nc   \n",
       "41120                            NaN         NaN  32153144.0        unk   \n",
       "28439  10.1016/s0002-9440(10)62301-2         NaN  15743792.0  els-covid   \n",
       "38895                            NaN  PMC1602352  15743792.0        unk   \n",
       "\n",
       "                                                abstract publish_time  \\\n",
       "29489                                                NaN   2019-03-31   \n",
       "16421                                                NaN   2019-02-27   \n",
       "16419  Highly infectious diseases (HIDs) are defined ...   2015-06-22   \n",
       "29293  Abstract Highly infectious diseases (HIDs) are...   2019-04-30   \n",
       "28740                                                NaN   2003-08-02   \n",
       "...                                                  ...          ...   \n",
       "28771                                                NaN   1983-06-04   \n",
       "15934                                                NaN   2020-03-10   \n",
       "41120                                                NaN         2020   \n",
       "28439  Mice infected with mouse hepatitis virus strai...   2005-03-31   \n",
       "38895  Mice infected with mouse hepatitis virus strai...   2005-03-23   \n",
       "\n",
       "                                                 authors  \\\n",
       "29489                                      Zwizwai, Ruth   \n",
       "16421                                      Zwizwai, Ruth   \n",
       "16419  Schilling, S.; Maltezou, H.C.; Fusco, F.M.; De...   \n",
       "29293  Schilling, S.; Maltezou, H.C.; Fusco, F.M.; De...   \n",
       "28740            de Leon, Samuel Ponce; Lazcano, Antonio   \n",
       "...                                                  ...   \n",
       "28771              Butler, MerlinG.; Palmer, CatherineG.   \n",
       "15934                 Song, Young Goo; Shin, Hyoung-Shik   \n",
       "41120                 Song, Young Goo; Shin, Hyoung Shik   \n",
       "28439                     Kim, Taeg S.; Perlman, Stanley   \n",
       "38895                     Kim, Taeg S.; Perlman, Stanley   \n",
       "\n",
       "                                   journal  Microsoft Academic Paper ID  \\\n",
       "29489       The Lancet Infectious Diseases                          NaN   \n",
       "16421                    Lancet Infect Dis                          NaN   \n",
       "16419                Clin Microbiol Infect                          NaN   \n",
       "29293  Clinical Microbiology and Infection                          NaN   \n",
       "28740                           The Lancet                          NaN   \n",
       "...                                    ...                          ...   \n",
       "28771                           The Lancet                          NaN   \n",
       "15934                     Infect Chemother                          NaN   \n",
       "41120                     Infect Chemother                          NaN   \n",
       "28439    The American Journal of Pathology                          NaN   \n",
       "38895                                  NaN                          NaN   \n",
       "\n",
       "      WHO #Covidence  has_pdf_parse  has_pmc_xml_parse      full_text_file  \\\n",
       "29489            NaN          False              False      custom_license   \n",
       "16421            NaN          False               True      custom_license   \n",
       "16419            NaN           True               True      custom_license   \n",
       "29293            NaN           True              False      custom_license   \n",
       "28740            NaN           True              False      custom_license   \n",
       "...              ...            ...                ...                 ...   \n",
       "28771            NaN           True              False      custom_license   \n",
       "15934            NaN           True               True  noncomm_use_subset   \n",
       "41120          #6103          False              False                 NaN   \n",
       "28439            NaN           True              False      custom_license   \n",
       "38895            NaN          False              False                 NaN   \n",
       "\n",
       "                                                     url  \\\n",
       "29489      https://doi.org/10.1016/s1473-3099(19)30075-1   \n",
       "16421  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7...   \n",
       "16419  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7...   \n",
       "29293            https://doi.org/10.1111/1469-0691.12290   \n",
       "28740      https://doi.org/10.1016/s0140-6736(03)14040-8   \n",
       "...                                                  ...   \n",
       "28771      https://doi.org/10.1016/s0140-6736(83)92745-9   \n",
       "15934  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7...   \n",
       "41120      https://www.ncbi.nlm.nih.gov/pubmed/32153144/   \n",
       "28439      https://doi.org/10.1016/s0002-9440(10)62301-2   \n",
       "38895  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1...   \n",
       "\n",
       "                                          title_abstract  \n",
       "29489                                                     \n",
       "16421                                                     \n",
       "16419  transportation capacity for patients with high...  \n",
       "29293  transportation capacity for patients with high...  \n",
       "28740                                                     \n",
       "...                                                  ...  \n",
       "28771                                                     \n",
       "15934                                                     \n",
       "41120                                                     \n",
       "28439  virus-specific antibody, in the absence of t c...  \n",
       "38895  virus-specific antibody, in the absence of t c...  \n",
       "\n",
       "[68 rows x 19 columns]"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Non-unique cord_uids\n",
    "duplicated_cord_uid_df = metadata_df[metadata_df.duplicated(subset=['cord_uid'], keep=False)]\n",
    "duplicated_cord_uid_df.sort_values(by='cord_uid')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Functions for mapping cord_uids to text files, to make retrieval of specific papers faster\n",
    "#Not yet using these\n",
    "\n",
    "def extract_column_from_pq_file(pq_file, col, unique_flag=False):\n",
    "    \n",
    "    print(\"Extracting %s values from %s...\" % (col, pq_file))\n",
    "    pq_df = pd.read_parquet(pq_file)\n",
    "    \n",
    "    if unique_flag:\n",
    "        res_list = set(pq_df[col].tolist())\n",
    "    else:\n",
    "        res_list = pq_df[col].tolist()\n",
    "    \n",
    "    print(\"Number of %s values extracted from %s: %d\" % (col, pq_file, len(res_list)))\n",
    "    \n",
    "    return res_list\n",
    "    \n",
    "def map_pq_files_to_col_vals(pq_files, col, outfile= '', unique_flag=False):\n",
    "    \n",
    "    res_dict = {}\n",
    "    \n",
    "    for pq_file in pq_files:\n",
    "        pq_name = pq_file.split('.')[0]\n",
    "        res_dict[pq_file] = extract_column_from_pq_file(pq_file, col, unique_flag)\n",
    "    \n",
    "    if outfile:\n",
    "        with open(outfile, 'w') as f:\n",
    "            json.dump(res_dict)\n",
    "    \n",
    "    return res_dict\n",
    "\n",
    "def map_col_vals_to_pq_files(pq_files, col, outfile = '', unique_flag=False):\n",
    "    \n",
    "    res_dict = {}\n",
    "    \n",
    "    for pq_file in pq_files:\n",
    "        col_vals_in_pq = extract_column_from_pq_file(pq_file, col, unique_flag)\n",
    "        for col_val in col_vals_in_pq:\n",
    "            res_dict.setdefault(col_val, []).append(pq_file)\n",
    "    \n",
    "    if outfile:\n",
    "        print(\"Writing dict to %s\" % outfile)\n",
    "        with open(outfile, 'w') as f:\n",
    "            json.dump(res_dict, f)\n",
    "    \n",
    "    return res_dict\n",
    "\n",
    "def generate_file_list_for_extraction(col_val_files_dict, col_vals):\n",
    "    \n",
    "    file_list = set([])\n",
    "    \n",
    "    for col_val, files in col_val_files_dict.items():\n",
    "        for file in files:\n",
    "            file_list.add(file)\n",
    "            \n",
    "    return file_list\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText1.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText1.parquet: 2375\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText4.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText4.parquet: 2772\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText8.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText8.parquet: 2325\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText10.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText10.parquet: 1188\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText3.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText3.parquet: 2065\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText0.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText0.parquet: 2512\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText12.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText12.parquet: 1855\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText15.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText15.parquet: 1881\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText2.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText2.parquet: 2440\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText6.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText6.parquet: 2195\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText19.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText19.parquet: 13962\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText18.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText18.parquet: 1861\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText11.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText11.parquet: 2420\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText13.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText13.parquet: 1101\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText5.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText5.parquet: 1966\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText7.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText7.parquet: 2205\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText17.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText17.parquet: 1873\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText16.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText16.parquet: 1898\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText14.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText14.parquet: 1887\n",
      "Extracting cord_uid values from resources/v8_preprocessed/v8processedText9.parquet...\n",
      "Number of cord_uid values extracted from resources/v8_preprocessed/v8processedText9.parquet: 1725\n",
      "Writing dict to cord_uids_pq_file_map_v8_200425.json\n"
     ]
    }
   ],
   "source": [
    "cord_uids_pq_files_dict = map_col_vals_to_pq_files(pq_files, 'cord_uid', outfile='cord_uids_pq_file_map_v8_200425.json', unique_flag=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "Functions to generate regex match patterns from synonymous words/phrases for filtering subject headers\n",
    "\"\"\"\n",
    "\n",
    "import re\n",
    "\n",
    "def extract_regex_pattern(section_list, pattern):\n",
    "    r = re.compile(pattern, re.IGNORECASE)\n",
    "    extracted_list = list(filter(r.match, section_list))\n",
    "    remaining_list = list(set(section_list) - set(extracted_list))\n",
    "    \n",
    "    return remaining_list, extracted_list\n",
    "\n",
    "def construct_regex_match_pattern(terms):\n",
    "    terms = ['.*%s.*' % i for i in terms]\n",
    "    pattern = '|'.join(terms)\n",
    "    return pattern"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'section_counts_dict' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-9-cc034e82ac50>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0munique_sections\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mstr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[0;32min\u001b[0m \u001b[0msection_counts_dict\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mkeys\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0;31m#Examples\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;31m#figure and table references\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'section_counts_dict' is not defined"
     ]
    }
   ],
   "source": [
    "unique_sections = [str(i) for i in section_counts_dict.keys()]\n",
    "\n",
    "#Examples\n",
    "#figure and table references\n",
    "\n",
    "figref_terms = ['figref', 'tabref', 'figure']\n",
    "figref_pattern = construct_regex_match_pattern(figref_terms)\n",
    "remaining_list, extracted_list = extract_regex_pattern(unique_sections, figref_pattern)\n",
    "print(\"Figure and table reference headers:\")\n",
    "print(extracted_list)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "Determine how many unique papers have at least 1 discussion section using one of the discussion/conclusion headers.\n",
    "\n",
    "conclusion\n",
    "discussion\n",
    "interpretation\n",
    "added value of this study\n",
    "research in context\n",
    "concluding\n",
    "closing remarks\n",
    "summary of findings\n",
    "\"\"\"\n",
    "\n",
    "\"\"\"\n",
    "for header, count in section_counts_dict.items():\n",
    "    if count > 1 and count < 5:\n",
    "        print(header)\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      ".*conclusion.*|.*discussion.*|.*interpretation.*|.*added value of this study.*|.*research in context.*|.*concluding.*|.*closing remarks.*|.*summary of findings.*|.*outcome.*\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "Construct regex pattern for discussion header terms and extract list of matching headers.\n",
    "\n",
    "\"\"\"\n",
    "discussion_terms = [\n",
    "    'conclusion',\n",
    "    'discussion',\n",
    "    'interpretation',\n",
    "    'added value of this study',\n",
    "    'research in context',\n",
    "    'concluding',\n",
    "    'closing remarks',\n",
    "    'summary of findings',\n",
    "    'outcome'\n",
    "]\n",
    "\n",
    "conc_pattern = construct_regex_match_pattern(discussion_terms)\n",
    "print(conc_pattern)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'unique_sections' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-8-451baaf10ff9>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mrem_header_list\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mext_header_list\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mextract_regex_pattern\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0munique_sections\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mconc_pattern\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0;32mwith\u001b[0m \u001b[0mopen\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'discussion_headers_list_200429.txt'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'w'\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mf\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mext_header\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mext_header_list\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'unique_sections' is not defined"
     ]
    }
   ],
   "source": [
    "rem_header_list, ext_header_list = extract_regex_pattern(unique_sections, conc_pattern)\n",
    "\n",
    "with open('discussion_headers_list_200429.txt', 'w') as f:\n",
    "    \n",
    "    for ext_header in ext_header_list:\n",
    "        f.write(\"%s\\t%d\\n\" %(ext_header, section_counts_dict[ext_header]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 298,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UIDs containing at least 1 of the extracted headers: 1687\n",
      "UIDs not containing any of the extracted headers: 2736\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "Determine how many uids contain at least 1 of the extracted headers.\n",
    "\"\"\"\n",
    "\n",
    "covered_uids = set([])\n",
    "\n",
    "for header in ext_header_list:\n",
    "    for uid in section_uids_dict[header]:\n",
    "        covered_uids.add(uid)\n",
    "    \n",
    "uncovered_uids = set(covid19_uid_list) - covered_uids\n",
    "\n",
    "print(\"UIDs containing at least 1 of the extracted headers: %d\" % len(covered_uids))\n",
    "print(\"UIDs not containing any of the extracted headers: %d\" % len(uncovered_uids))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 299,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "Determine the reasons for the 2753 uncovered uids.\n",
    "\"\"\"\n",
    "\n",
    "uid_sect_header_artifacts = {\n",
    "    'uids_with_body_text': set([]),\n",
    "    'uids_with_only_title_and_abstract' : set([]),\n",
    "    'uids_with_no_text' : set([]),\n",
    "    'unaccount_uids' : set([])\n",
    "\n",
    "}\n",
    "\n",
    "unaccount_uids = set([])\n",
    "for uid in list(uncovered_uids):\n",
    "    \n",
    "    sect_headers = uid_section_headers_dict.get(uid)\n",
    "    account_flag = 0\n",
    "    if sect_headers:\n",
    "        \n",
    "        if len(set(sect_headers) - set(['abstract', 'title'])) == 0:\n",
    "            uid_sect_header_artifacts['uids_with_only_title_and_abstract'].add(uid)\n",
    "            account_flag = 1\n",
    "        elif 'body_text' in sect_headers:\n",
    "            uid_sect_header_artifacts['uids_with_body_text'].add(uid)\n",
    "            account_flag = 1\n",
    "    else:\n",
    "        uid_sect_header_artifacts['uids_with_no_text'].add(uid)\n",
    "        account_flag = 1\n",
    "    \n",
    "    if account_flag == 0:\n",
    "        uid_sect_header_artifacts['unaccount_uids'].add(uid)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 300,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "uids_with_body_text 400\n",
      "uids_with_only_title_and_abstract 1129\n",
      "uids_with_no_text 781\n",
      "unaccount_uids 426\n"
     ]
    }
   ],
   "source": [
    "total_uids = set([])\n",
    "\n",
    "for art_type, uids in uid_sect_header_artifacts.items():\n",
    "    print(art_type, len(uids))\n",
    "    \n",
    "    for uid in uids:\n",
    "        total_uids.add(uid)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 301,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "j40zj4al\n",
      "{'body_text', '114', '232', 'title', 'abstract', '(which was not peer-reviewed)', '115', '317'}\n",
      "1mchg5yg\n",
      "{'body_text', 'abstract', 'title'}\n",
      "f87h5qh6\n",
      "{'body_text', 'abstract', '5', 'title'}\n",
      "c800ynvc\n",
      "{'body_text', 'abstract', 'title'}\n",
      "umqowine\n",
      "{'body_text', 'title', 'abstract', '11', '(which was not peer-reviewed)', '57.'}\n",
      "8g70j0qw\n",
      "{'body_text', 'abstract', 'title'}\n",
      "z2g1mx1p\n",
      "{'body_text', 'A Framework for Collecting and Sharing Data', 'title', 'Introduction', 'abstract', 'The Need for Information'}\n",
      "0xciml6s\n",
      "{'body_text', 'Additional Resources', 'Environment', 'Imaging Logistics During Pandemic', 'COVID-19 on a CT scan. (Q14)', 'title', 'This', 'abstract', 'CT scan is indicated in a patient who has functional impairment and/or hypoxemia after recovery from COVID-19 (Q13)', 'Resource constraints', 'Scenario 1: Mild Features of COVID-19', 'Scenario 2: Moderate to Severe Features of COVID-19', 'Disease progression', 'The Use of Imaging in COVID-19', 'Daily chest radiographs are not indicated in stable intubated patients with COVID-19 (Q12)'}\n",
      "jof8lij8\n",
      "{'body_text', 'abstract', 'title', 'Mitigate the effects of home confinement on children during the COVID-19 outbreak'}\n",
      "q1vjw73k\n",
      "{'body_text', 'abstract', 'title'}\n",
      "eifrg2fe\n",
      "{'title', '427', '240', '369', '264', '334', '327', '280', '157', '420', '315', '435', '311', '215', '281', '249', '236', 'body_text', '498', '325', 'abstract', '458', '395', '466', '216', '203'}\n",
      "9i0a9beo\n",
      "{'body_text', 'abstract', 'title'}\n",
      "dbwfn27p\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', 'Method'}\n",
      "rmn7qyrx\n",
      "{'body_text', 'Introducción.', 'title', 'abstract', 'Management of neurological care during the COVID-19 pandemic', 'Decisiones operativas.'}\n",
      "nv70mlae\n",
      "{'body_text', 'title', 'abstract', 'Funding and ethics approval', 'Conflicts of interest', 'Author contributions'}\n",
      "m5u3cnvh\n",
      "{'body_text', 'abstract', 'title'}\n",
      "nzat41wu\n",
      "{'body_text', 'abstract', 'title'}\n",
      "944w4qgq\n",
      "{'body_text', 'abstract', 'title'}\n",
      "0qwwycnc\n",
      "{'body_text', 'abstract', 'title'}\n",
      "q4i9kh65\n",
      "{'body_text', '58', 'title', 'hospitalization. 53', 'abstract'}\n",
      "ic2h01gm\n",
      "{'body_text', 'abstract', 'title'}\n",
      "mo4luyx6\n",
      "{'body_text', 'title', 'Ferret Study', 'abstract', 'Plaque reduction neutralization test', 'Cat study', 'Histological study', 'Dog, pig, chickens, and duck study'}\n",
      "leysxvf2\n",
      "{'body_text', 'abstract', 'title'}\n",
      "vu7u11yk\n",
      "{'body_text', 'An immunogenic domain in the S2 subunit of SARS-CoV is highly conserved in SARS-', 'title', 'abstract', 'CoV-2 but not in endemic coronaviruses', 'Mab1A9 binds to S expressed in SARS-CoV-2-infected cells', '0'}\n",
      "itcuh8ed\n",
      "{'title', 'Management of infection prevention and control in interventional clinics', 'Personal protection for medical personnel [3]', '4.3.3.2', '2.3', '2.2', 'Screening of newly admitted patients', '4.3.3.3', '2.4', 'Protect the medical needs according to the criticality and severity of the tumors', 'Surgery', '4.3.3.4', 'Emergency interventional operations', 'body_text', 'Other recommendations', 'abstract', 'Final words', '4.3.1.4', '4.3.1.5', 'Patient management', 'Implement rigorous standard prevention measures, focused on wearing surgical face masks and hand hygiene to avoid nosocomial infections'}\n",
      "54mx8v4i\n",
      "{'body_text', '12', 'title', '13', 'abstract', '21', '9', '17', '15', '2'}\n",
      "7eed7ifd\n",
      "{'body_text', 'abstract', 'Restrict (restrict number of visits, generation of aerosols, restrict visitors)', 'title'}\n",
      "i8w88cb0\n",
      "{'body_text', 'Ethical consideration', 'title', 'abstract', 'Multi-modal education of patients and accompanying persons', 'Results', 'Quality improvement based on digitized feedback', '. Refined management is crucial for epidemic prevention and control', 'Challenges to COVID-19 prevention and control'}\n",
      "hoybp1h6\n",
      "{'body_text', 'abstract', 'title'}\n",
      "dptgg05n\n",
      "{'body_text', 'Isolation of PBMC', 'title', 'abstract', 'Ethics statement', 'Neutralizing antibody assay', 'Expression and Purification of recombinant proteins', 'Anti-SARS-CoV-2 IgG/IgM ELISA'}\n",
      "7vuejy26\n",
      "{'body_text', 'Materials and Methods', 'title', 'abstract', '15', 'Fig. 2. Haplotype network using genome-wide single nucleotide variations (HN-GSNVs).', 'Fig. 1. Whole genome sequence of SARS-CoV-2 isolates (strains) on the Diamond Princess (DP) cruise ship off Yokohama in Japan.'}\n",
      "0ygaj2hm\n",
      "{'body_text', 'title', 'abstract', '25', '15'}\n",
      "w7tbegc7\n",
      "{'body_text', 'abstract', 'title'}\n",
      "wx7nheay\n",
      "{'body_text', 'abstract', 'title', '76'}\n",
      "y90w53xo\n",
      "{'body_text', 'title', 'abstract', \"Authors' contributions\", 'Funding', 'Declaration of Competing Interest'}\n",
      "9qd61n3p\n",
      "{'title', 'Virologic diagnosis', 'Replicase', 'The virus', 'Transmission', 'Vaccines', 'Molecular evolution', 'Extrapulmonary pathology', 'Clinical features of SARS', 'Ribavirin', 'Monoclonal antibody therapy', 'Clinical laboratory findings', 'Viral assembly and exit', 'Expression of other SARS-CoV genes', 'Emergence and origin of SARS-CoV', 'Drugs that target viral proteases', 'Accessory proteins', 'SARS-CoV genome, proteome, and replication cycle', 'Pathology of SARS-CoV pneumonia', 'Spike protein and receptor-based entry', 'Drug therapy', 'Interferons', 'Implications for the future', 'body_text', 'Immune response', 'Ultrastructure of SARS-CoV', 'abstract', 'Therapy by blocking viral entry', 'Other antiviral therapies', 'Viral countermeasures'}\n",
      "2dsesgof\n",
      "{'body_text', 'abstract', 'title'}\n",
      "wolpnbxa\n",
      "{'body_text', 'title', 'abstract', 'Structural analysis', 'Annotation of SARS-CoV-2 E from 3,449 SARS-CoV-2 genomes deposited in GISAID', 'Interactome analysis'}\n",
      "zksa523r\n",
      "{'body_text', 'abstract', 'title'}\n",
      "ju9japd8\n",
      "{'body_text', 'This suggests that the large-scale surveillance and intervention measures implemented in Guangdong', 'Virus amplification and sequencing', 'title', 'abstract', 'Phylogenetic analysis', '(which was not peer-reviewed)', 'Sample collection, clinical surveillance and epidemiological data', 'Virus genome assembly', 'Acknowledgments & Funding', 'Data Availability', 'Ethics'}\n",
      "mcevx6lx\n",
      "{'body_text', 'abstract', 'title', 'Supplementary Information'}\n",
      "iyv86437\n",
      "{'body_text', 'abstract', 'title'}\n",
      "vtjsigod\n",
      "{'body_text', 'Research', 'Open Access', 'Education and training of staff', 'title', 'abstract', 'Early case recognition and classification of disease severity', 'Novel coronavirus infection special intensive care team', 'Bed and medical equipment preparation', 'Protection of medical staff', 'Conflicts of interest', 'Electronic supplementary material', \"Publisher's Note\", 'Funding', 'Strict restriction of patient contact'}\n",
      "ckh8jp9e\n",
      "{'body_text', 'abstract', 'title'}\n",
      "2okcuviq\n",
      "{'body_text', 'abstract', 'COVID-19 and showed huge diversities of TCR and BCR clones in each individual.', 'title'}\n",
      "3y89lumh\n",
      "{'body_text', 'abstract', 'title', 'South Korea'}\n",
      "kyx422j1\n",
      "{'body_text', 'title', '125', 'abstract', '238', '81', '205'}\n",
      "5ekdfers\n",
      "{'body_text', 'Statistical analysis', 'title', 'abstract', 'Patients', 'Ethics statement', 'Declaration of interests', 'Author contributions'}\n",
      "ej1b1x53\n",
      "{'body_text', '381', 'title', 'abstract', '341', '537', '350', '367'}\n",
      "7hqn997j\n",
      "{'body_text', 'abstract', '10', 'title'}\n",
      "ctd9sutv\n",
      "{'body_text', 'Microbes and Infection', 'title', 'abstract', 'Declaration of Competing Interest'}\n",
      "mbdah9ey\n",
      "{'body_text', '254', 'title', 'abstract', '97', '165', '169', '126', '327', '142'}\n",
      "7t41wvw3\n",
      "{'187', 'title', '179', '90', '176', '170', '71', '128', '168', '(which was not peer-reviewed)', '171', '113', '235', '189', '88', '126', 'body_text', '272', '127', '229', 'abstract'}\n",
      "ih1py5n9\n",
      "{'body_text', 'abstract', 'title'}\n",
      "c1n994j6\n",
      "{'body_text', 'abstract', 'title', '22'}\n",
      "c3dxfet9\n",
      "{'body_text', 'title', '2 8', 'abstract', '4 3', '5 2', '9 6'}\n",
      "dnxhtbxn\n",
      "{'body_text', 'title', 'abstract', 'Data used in the study', 'Recent coronavirus zoonotic transmissions have involved non-bat intermediates. Indeed, both SARS 15', 'Results', 'Analysis'}\n",
      "st5vs6gq\n",
      "{'body_text', 'Model Comparison', 'Figure S2. Number of infections per unique index case in the infection report data set.', 'title', 'abstract', 'Data', '(which was not peer-reviewed)', 'One sentence summary', 'Table S1. Estimate d serial interval distributions based on the location of index infection (imported versus local) and the secondary infection (household versus non-household).', 'Supplementary Analysis', 'Estimating serial interval distribution'}\n",
      "mlkxcn5k\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', '<0.001 Laboratory findings on admission to hospital', '4 7', 'CC-BY-NC-ND 4.0 International license'}\n",
      "eedk54xf\n",
      "{'body_text', '119', '358', 'title', '125', 'abstract', '323', '178', '179', '250', 'Results', 'Results from WuHan city 247'}\n",
      "uc225mhn\n",
      "{'body_text', 'title', 'abstract', 'Assumptions', 'Origins of Consensus Statement', 'Process of priority status determination for individual patients', 'Final Thought', 'Shared Decision Making and Transparency'}\n",
      "ai9jh0xu\n",
      "{'body_text', 'abstract', 'title'}\n",
      "jvm1pcjy\n",
      "{'title', 'Equipment Disinfection', 'OR Disinfection', 'Healthcare Providers', 'ARTICLE IN PRESS', 'Patient Transport', 'Equipment Preparation', 'Perioperative Blood Management in COVID-19 Patients', 'Cardiovascular Manifestations of COVID-19', 'Preoperative Evaluation of COVID-19 Cardiac Surgical Patients', 'Anesthetic Management of Critically Ill COVID-19 Patients', 'Personal Protective Equipment for Healthcare Providers', 'Cardiac Patient Preparation', 'Medical Waste Management', 'Pulmonary Considerations in COVID-19 Patients', 'body_text', 'Renal Considerations in COVID-19 Patients', 'abstract', 'Intraoperative Management of COVID-19 Cardiac Surgical Patients', 'Staffing Management'}\n",
      "uxpwxc3u\n",
      "{'body_text', 'title', 'abstract', 'MERS-CoV y SARS-CoV', 'Coronavirus y esclerosis múltiple', 'El virus de la hepatitis de ratón', 'Conclusión', 'La epidemia de SARS-CoV-2 y la posibilidad de que el cerebro pueda ser reservorio del virus', 'Cuadro neurológicos por coronavirus'}\n",
      "mj8ebo7i\n",
      "{'body_text', 'Defining CoV and HRV infected groups and associated analysis 721', 'title', 'ALI cultures 828', 'abstract', '521', '499', 'GALA II study subjects 562', 'Effect Size t-test Predictor Model', '789', 'LD. 1194', '366'}\n",
      "6ymuovl2\n",
      "{'body_text', 'title', 'abstract', '(Figure 5)', 'The COVID-19 Epidemic Dynamics Without Intervention.'}\n",
      "qtrquuvv\n",
      "{'body_text', 'abstract', '(which was not peer-reviewed)', 'title'}\n",
      "cv32u0ox\n",
      "{'body_text', '7 0', 'title', '2 8', 'abstract', '9', '0 0', '9 6'}\n",
      "xfjexm5b\n",
      "{'body_text', '272', '127', '94', 'title', '268', '255', 'abstract', 'Awareness parameters', '181', '159', '295', '275', '154', 'Prevention measures', '283'}\n",
      "m81hfdpe\n",
      "{'body_text', 'abstract', 'title', 'Declaration of Competing Interest'}\n",
      "b4zr1g04\n",
      "{'body_text', 'abstract', '172', 'title'}\n",
      "94xxzksq\n",
      "{'body_text', 'Dsicussion', 'title', 'abstract', 'Patients', 'Objectives', 'Epidemiological data', 'Data collection', 'Demographics and Clinical manifestations', 'Ethical Approval', 'Declaration of Competing Interest'}\n",
      "98syj71y\n",
      "{'body_text', 'title', 'abstract', '135', '73'}\n",
      "7ic5zvge\n",
      "{'body_text', 'OPTIMIZE PHYSICAL SPACE', 'title', 'PERFORM A MOCK VIRTUAL INTERVIEW', 'abstract', 'PREPARE TECHNOLOGICAL PLATFORMS', 'TABLE 1. Examples of Virtual Interview Distractions'}\n",
      "rvdkkr6i\n",
      "{'body_text', '229', 'title', 'abstract', 'Selection of relevant epidemiological parameters for COVID-19', '338'}\n",
      "d950qa2w\n",
      "{'body_text', '4', 'title', 'abstract', '(which was not peer-reviewed)'}\n",
      "qyf59ghf\n",
      "{'body_text', 'abstract', 'title'}\n",
      "athjtu2j\n",
      "{'body_text', '\"Herd Immunity\" is not suitable for prevention and control strategies in outbreak of infectious diseases', 'Qingfei Paidu Decoction', 'Shufeng Jiedu Capsule', 'title', 'Fig. 5. Structures of polyphenols in tea', 'abstract', 'Pneumonia No.1 Formula', 'WHO: Novel coronavirus epidemic for outbreak a pandemic Novel', 'Epidemiological dynamics is a basis to establish the healthcare system capacity to meet the needs of the epidemic', 'Effective prescription for treatment of COVID-19 pneumonia 4.1.1. Hospital preparations', 'Summary', 'TCM advantages in treatment of SARS-CoV-2 infection', 'Basic research on compatibility of traditional Chinese medicine was expounded by using the synergetic effect of multi-targets', 'The ability to recognize the virus infecting: Basic infection number (R0)'}\n",
      "tevmxm59\n",
      "{'body_text', '157', '35', '94', 'title', '226', 'abstract', '158', '248', '89', '245', '244', '31'}\n",
      "96r8l6vq\n",
      "{'body_text', 'abstract', '222', 'title'}\n",
      "4gaa14ly\n",
      "{'body_text', 'abstract', 'title'}\n",
      "4z2myiet\n",
      "{'body_text', 'abstract', 'title'}\n",
      "zbp8jzbe\n",
      "{'body_text', 'Purification of ZIKV viral protein complexes', 'Genome-wide screens for SARS-CoV-2 intra-viral protein-protein interactions', 'Global proteome profiling of PBMCs from COVID-19 patients', 'title', 'AUTHOR CONTRIBUTION', 'abstract', 'SARS-CoV-2 nsp9 and nsp10 target NKRF to facilitate IL-8/IL-6 production', 'Ethics statement', 'Cell lines, plasmids, and antibodies', 'Virus-host Interaction network analysis'}\n",
      "769aw2iv\n",
      "{'body_text', 'title', 'abstract', 'The Role of the Conjunctiva in COVID-19', 'An Ophthalmologist Sounded the Alarm'}\n",
      "7odpslba\n",
      "{'body_text', '123', 'title', 'abstract', '(which was not peer-reviewed)', '129'}\n",
      "qb85uyzr\n",
      "{'body_text', 'abstract', 'title'}\n",
      "jecsj3xw\n",
      "{'body_text', 'title', 'Material and Methods', 'Statistical analysis', 'abstract', 'Hematology Findings of COVID-19 patients', 'Figure 2 ROC analysis using single and combined parameters in the diagnosis of severe cases of COVID-19', '(which was not peer-reviewed)', 'Summary', 'Biochemical and coagulation test findings of COVID-19 patients', 'Data collection', 'Demographic and clinical characteristics of COVID-19 patients', 'LDA for combined parameters', 'Figure 1 The comparison for significant CBC parameters between moderate and severe type of COVID-19 patients'}\n",
      "wuvry51z\n",
      "{'body_text', 'Concentrator 5 columns (Zymo Research). RNA was quantified by Nanodrop and Qubit 237', 'title', 'abstract', 'FIGURE LEGENDS 161'}\n",
      "3fflt6a3\n",
      "{'title', 'Lifestyle aspects', 'Legal aspects', 'Stronger knowledge and science provision in understanding disaster and health-related emergency risks', 'Strengthen community-level preparedness and response', 'Prepare inclusive early recovery plans', 'Learning from prior experiences makes a difference', 'National level', 'Health and science aspects', 'Regional level', 'Understand COVID-19 economic implications and resilience', 'Asia', 'Responses to COVID-19 from global to national level', 'Europe', 'body_text', 'North America', 'abstract', 'Global level', 'Recommendations on how current strategies for disaster resilience can contribute to responses to COVID-19'}\n",
      "4k9m9xe4\n",
      "{'body_text', 'abstract', 'the nitro-tyrosine via FRET and fluorescence is quenched. (B) Once the substrate is cleaved by 3CL pro , the donor and acceptor', 'title'}\n",
      "cycc3fvl\n",
      "{'body_text', '318', '206', 'title', 'Stability analysis and simulations 249', 'abstract', '125', '277', '261', '197', '374', '151', '241', '413', '446', '330'}\n",
      "rlpzejjt\n",
      "{'body_text', 'abstract', 'title'}\n",
      "8p1agcm2\n",
      "{'body_text', 'Selection of coronavirus proteome sequences for comparison to 2019-nCoV', 'title', 'abstract', 'ACKNOWLEDGEMENTS', 'Protein sequences from natural virus isolates with sequences identical to the SARS-CoV and', 'B cell epitope prediction on 2019-nCoV isolate', 'IEDB analysis of T and B epitopes derived from coronaviruses', 'Determination of 2019-nCoV sequence conservation', 'T cell epitope prediction on a 2019-nCoV isolate.'}\n",
      "nqauuzw0\n",
      "{'body_text', 'title', 'abstract', 'Results', 'MoH. 152'}\n",
      "2g8rfzf4\n",
      "{'body_text', 'abstract', 'title', 'Figure 1: Evaluating the plausibility of subcritical transmission.'}\n",
      "g68g6xxu\n",
      "{'body_text', 'title', 'abstract', 'Box 1. Interpreting cumulative skew diagrams', 'Box 2. Coronavirus replication and transcription in SARS-CoV'}\n",
      "hiw576og\n",
      "{'body_text', 'abstract', 'title', '32'}\n",
      "tne83uu0\n",
      "{'body_text', '94', 'title', 'abstract', '248', 'Sources of Data', '247'}\n",
      "ptqzvsdw\n",
      "{'body_text', '630', 'title', '452', 'abstract', '363', '148', '447', '253', '632'}\n",
      "rxv5lgq8\n",
      "{'Intensity and length of \"general contact reduction\" starting on day 5 of the simulation', 'title', 'Parameter', 'Symptomatic period 10 days', '(which was not peer-reviewed)', 'Latency period 4 days', 'Seasonality effect', 'General contact reduction', '50%', 'Proportion of cases in hospital isolation (with home isolation at 50% effectiveness when hospital capacity is exceeded; beginning on day 5 of the simulation)', '40%', 'Appendix: Description of the CovidSIM model and model input parameters', 'Controls end day 189', 'Parameters used in the modelling with CovidSIM', 'body_text', 'abstract', 'Value/s used Further details', '25%', 'Contact reduction begins 19'}\n",
      "pgxew3yk\n",
      "{'body_text', 'title', 'abstract', 'Homology Modeling of Spike Protein', 'A B', 'Molecular Docking', 'Spike Glycoprotein'}\n",
      "oc584x1k\n",
      "{'body_text', 'abstract', 'University of Washington:', 'title'}\n",
      "yb6if23t\n",
      "{'body_text', 'title', 'abstract', 'Electronic supplementary materials', 'Except for three main larger clades [named', 'Table S1'}\n",
      "kjkfsy7w\n",
      "{'body_text', 'title', \"The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy\", 'abstract', 'Figure: EMS organisation and procedural algorithm of the COVID-19 Response Team'}\n",
      "mqwgrwdb\n",
      "{'body_text', 'abstract', 'title'}\n",
      "v73bsrwg\n",
      "{'body_text', 'abstract', 'title'}\n",
      "2hgwa6pq\n",
      "{'body_text', 'abstract', 'Fig. 3. A) and B) Model of SARS-CoV-2 structure provided by SWISSMODEL and visualized with Jmol.', 'title'}\n",
      "yk9u4fvp\n",
      "{'body_text', 'Which of the following is correct about transmission route of novel coronavirus?', 'title', 'Measures for Themselves/Others', 'abstract', 'Which of the following is correct about the definition of novel coronavirus?'}\n",
      "rxrlbw60\n",
      "{'body_text', 'Coronavirus animal reservoirs and incidental hosts', 'Travel-related cases', 'Current state of knowledge and knowledge gaps', 'Clinical Disease and Pathogenesis of 2019-nCov and other Coronaviruses', 'title', 'Receptor Binding Domain (RBD) Alignment, Predictions, and Modeling', 'abstract', 'Future Directions', 'Molecular virology', 'Animal model development', 'Vaccines and Community Readiness Vaccine development', 'Molecular Analysis of 2019-nCoV The CoV Spike protein and host receptors', 'Community Readiness', 'Phylogenetic Tree Analysis', 'Therapeutics and supportive care'}\n",
      "j5psma9i\n",
      "{'body_text', 'abstract', 'title', 'Q.A. Ahmed and Z.A. Memish'}\n",
      "99sbhbuo\n",
      "{'body_text', 'title', 'abstract', 'Results 47', 'Muc4 impacts pathogenesis for an unrelated virus 145', '. Estrogen increases 226', 'Muc4 -/mice have augmented inflammation 136', 'CHIKV infection is representative of systemic disease and is exacerbated in the absence of 243', 'Data Availability 338', 'Lung Titration 284', 'Lung function altered in Muc4-/-female mice 118', 'Cytokine Analysis 293'}\n",
      "x3n6uj21\n",
      "{'body_text', 'title', 'Abstract', 'abstract', 'Correspondence'}\n",
      "mopydeq5\n",
      "{'body_text', '132', 'title', '99', '125', 'abstract', '(which was not peer-reviewed)', '115', '137'}\n",
      "a0xfb9l4\n",
      "{'body_text', 'title', 'abstract', 'Construction of tetracycline-inducible expression system. Stable tetracycline inducible', 'Generation of TDRD3 and TOP3B knockout cells by the CRISPR/Cas9 system. To generate'}\n",
      "63hs1loe\n",
      "{'254', '225', 'title', '377', '142', '185', '172', '86', '89', '147', '92', '156', '77', '328', '175', '303', '298', '189', '239', 'body_text', 'abstract', '151', '124', '169'}\n",
      "eyi5609q\n",
      "{'body_text', '35', '226', 'title', '54', 'abstract', '5/12', '56', '257', '248', '40', '252', '62'}\n",
      "kwdvais7\n",
      "{'body_text', 'abstract', 'Has China faced only a herald wave of SARS-CoV-2?', 'title'}\n",
      "c94vw0vo\n",
      "{'body_text', 'title', 'Region', 'abstract', '11', '152', '37', '7', '15', '154', '8', '16'}\n",
      "9sk11214\n",
      "{'404', 'title', '153', '271', '19/32', 'Temporal dynamics of individual viral subtypes across different regions 357', '75', '275', '9/32', '150', '475', '102', '391', '262', '425', '342', '24/32', '350', 'body_text', 'abstract', '432'}\n",
      "dqrp18c6\n",
      "{'body_text', 'abstract', 'title'}\n",
      "d9y31nlj\n",
      "{'120', '254', 'Check-points', 'title', '469', '117', '441', '252', '287', '185', '731', '587', '588', '172', '511', '453', '143', '440', '704', '311', '199', '150', '219', '544', '732', 'Measure type Description', '138', '242', '467', '755', '605', 'Community check-points', 'body_text', '256', '277', '758', '444', '463', 'abstract', '543'}\n",
      "ieobv7q8\n",
      "{'body_text', '4', 'title', 'Methodology and Results', '.', 'abstract'}\n",
      "q8p187qx\n",
      "{'body_text', 'abstract', 'title'}\n",
      "l352l3yk\n",
      "{'body_text', 'abstract', 'title'}\n",
      "j6y806qu\n",
      "{'body_text', '177', '318', 'title', '302', 'abstract', '121', '311', '342', '219'}\n",
      "x64cwmqf\n",
      "{'body_text', 'abstract', 'title'}\n",
      "4v48kkus\n",
      "{'body_text', 'abstract', 'title'}\n",
      "7acoduj3\n",
      "{'body_text', 'abstract', 'title'}\n",
      "fbwpw3jc\n",
      "{'body_text', 'abstract', 'title'}\n",
      "65lwy0dg\n",
      "{'body_text', 'abstract', 'Is Schizophrenia Research Relevant During the COVID-19 Pandemic?', 'title'}\n",
      "avo5jfaj\n",
      "{'body_text', 'Analysis of sensitivity 172', 'title', 'abstract', 'Ln (viral load) = α* Ln(F sample -F o ) (1) 266'}\n",
      "jpkxjn6e\n",
      "{'body_text', 'Molecular dynamic simulations', 'Structural modeling', 'title', 'abstract', 'Fig. S3.'}\n",
      "d13bq4ij\n",
      "{'body_text', 'title', 'abstract', '2020 in crisis', 'Social cooperation during the 2019-nCoV epidemic and lessons for future epidemic prevention', 'Declaration of Competing Interest'}\n",
      "y8o5j2be\n",
      "{'body_text', 'abstract', 'title'}\n",
      "4m9p717r\n",
      "{'body_text', '18', 'title', 'abstract', '165', '21', '24', '20', '239', '236', '219', '169'}\n",
      "50vo8bnc\n",
      "{'body_text', '3) Metastatic Epidural Spinal Cord Compression (MESCC):', 'title', 'Abstract', 'abstract', '5) Bone oligometastases and other SBRT (Stereotactic Body Radiation Therapy) indications:', '1) Painful bone metastasis:', '4) Adjuvant bone metastasis radiotherapy:'}\n",
      "73pm4aqw\n",
      "{'body_text', 'abstract', 'title'}\n",
      "g4mtpn2p\n",
      "{'body_text', 'abstract', '*Bassey Ebenso, Akaninyene Otu', 'title'}\n",
      "hlhfx3fm\n",
      "{'body_text', 'abstract', 'title'}\n",
      "nn15iyqd\n",
      "{'body_text', 'title', 'SARS-CoV2 and the acute respiratory distress syndrome', 'The role of the checkpoints inhibitors', 'abstract', 'Management of rheumatic patients during the CoViD-19 pandemic'}\n",
      "zqbume1i\n",
      "{'body_text', 'abstract', 'title'}\n",
      "erdity4m\n",
      "{'body_text', 'title', 'abstract', '109', '113', '194'}\n",
      "hlcgutzf\n",
      "{'body_text', 'abstract', 'title'}\n",
      "05w8tv8x\n",
      "{'body_text', 'Human ACE2 Missense Variants May Increase or Decrease its Binding to SARS-CoV-2 244', 'title', 'ACE2 is Generally Intolerant to Loss-of-function Variants 112', 'abstract', '86'}\n",
      "nugginc9\n",
      "{'body_text', 'abstract', 'title'}\n",
      "dycx8i7h\n",
      "{'body_text', 'abstract', 'title'}\n",
      "v0yzur5h\n",
      "{'body_text', 'abstract', 'Analysis stage', 'title'}\n",
      "9j5yda3k\n",
      "{'title', '106', '164', '172', '356', '143', '(which was not peer-reviewed)', '154', '91', 'Ethics approval and consent to participate 255', '55', 'Availability of data and materials 257', '138', '231', 'Disclaimer 259', 'Conflict of Interests 263', '63', 'body_text', '136', '141', '123', 'abstract', 'Data fitting with Boltzmann function and estimation of critical dates', '208'}\n",
      "obadq502\n",
      "{'body_text', 'abstract', 'title'}\n",
      "qed8hayx\n",
      "{'body_text', 'abstract', 'title'}\n",
      "ymi398ef\n",
      "{'body_text', 'title', 'Identification of SARS-CoV nucleocapsid protein', 'abstract', 'Determination of AP-1 activation with PathDetect system', 'TransFactor analysis', 'Materials and methods'}\n",
      "t8j4q00m\n",
      "{'body_text', 'abstract', 'title'}\n",
      "duzk4nq5\n",
      "{'body_text', 'abstract', 'title'}\n",
      "j8n06hzx\n",
      "{'body_text', 'abstract', 'title'}\n",
      "5j4nt2qs\n",
      "{'body_text', 'abstract', 'title'}\n",
      "7wtsw1cf\n",
      "{'body_text', 'title', 'abstract', 'Publication bias:', 'Grading the quality of evidence:'}\n",
      "idauypat\n",
      "{'body_text', 'Abstract', 'title', 'abstract', 'Daily basis estimation of the reproductive number'}\n",
      "5jai745w\n",
      "{'body_text', 'title', '138', '179', 'abstract', '339', '350', '292', '124'}\n",
      "lotyldfd\n",
      "{'body_text', 'title', 'abstract', 'Methods', 'Author Contributions', 'Summary', 'Presence of tyrosines and glycines in the ACE2 binding domains of these spike proteins'}\n",
      "59rcogfc\n",
      "{'body_text', 'abstract', 'title'}\n",
      "b6f6hek8\n",
      "{'Parenteral nutrition support', 'title', 'Rest and activities', 'Observation of disease condition', 'Maintaining a clear airway', 'Bed allocation', 'Oral care', 'Observation and nursing for drug administration', 'Establishment of the Consensus', 'Nursing care for patients with blood purification treatment', 'Priority health problems', 'Respiratory rehabilitation', 'Other health problems', 'Nursing goals', 'Psychological assessment', 'Skin care', 'For patients with oral food intake', 'Nursing care for patients with convalescent plasma therapy', 'Elimination care', 'Psychological nursing', 'Enteral nutrition support', 'Providing optimal oxygen therapy and respiratory care', 'body_text', 'Management of catheters', 'abstract', 'Fever nursing', 'Discharge instructions', 'Environmental assessment', 'Physical assessment', 'Target groups and protection levels', 'Nursing care for patients with extracorporeal membrane oxygenation'}\n",
      "ei2b8oqn\n",
      "{'body_text', 'abstract', 'title'}\n",
      "eflwztji\n",
      "{'body_text', 'title', 'Statistical analysis', 'abstract', 'Sources of Data', 'Competing interests', 'Methods', 'Ethics approval'}\n",
      "xgc54wtn\n",
      "{'body_text', 'abstract', 'title'}\n",
      "1rq612hm\n",
      "{'body_text', '232', 'title', 'abstract', '(which was not peer-reviewed)', '246', '264', '252', '241', '220'}\n",
      "a7u8xdux\n",
      "{'body_text', '77', 'Highlights (for review)', 'Materials and Methods', '172', 'title', 'abstract', 'Figure', '181', 'Distribution of Published Journals and Funding Agencies Focusing on Covid-', '152'}\n",
      "px0twvhs\n",
      "{'body_text', 'abstract', 'P. van den', 'title'}\n",
      "6gwnhkn4\n",
      "{'body_text', 'abstract', 'title'}\n",
      "cetdqgff\n",
      "{'body_text', '356', '119', 'title', '99', '116', 'abstract', '408', '97', '423', '324', '435', '264', '95', '192', '122'}\n",
      "vm0k7hfx\n",
      "{'body_text', 'Cytokine analysis:', 'Viral RNA quantification:', 'title', 'abstract', 'SARS-COV-2 infection and drug treatment:'}\n",
      "rfhtlodc\n",
      "{'body_text', 'Protein purification:', 'title', 'Bacterial genomic DNA extraction:', 'abstract', 'Sanger Sequencing:', 'MST Method:', 'Disease selection from ClinVar Database:', 'Human Genomic DNA extraction:', 'FnCas9 activity in a temperature range:', 'In vitro Cleavage assay (IVC):', 'Supplementary', 'Plasmid Construction:', '(Supplementary', 'Stability of the FnCas9 protein:', 'In vitro transcription (IVT):'}\n",
      "0wbu1yap\n",
      "{'body_text', 'abstract', 'title'}\n",
      "bxzprauu\n",
      "{'body_text', 'title', 'abstract', 'STATISTICAL ANALYSIS', 'Figure 1. Nomograms of Depression, Anxiety and Stress', 'NOMOGRAMS CONSTRUCTION AND INTERNAL VALIDATION', 'ROLE OF THE FUNDING SOURCE', 'REFERENCES', 'RESULTS'}\n",
      "c4dlym34\n",
      "{'body_text', 'title', 'abstract', 'Ethical approval', 'Funding', 'Declaration of competing interest'}\n",
      "6phwc7s7\n",
      "{'body_text', 'abstract', 'title', '8 9'}\n",
      "xs9lot5s\n",
      "{'body_text', 'abstract', 'title'}\n",
      "wws9ho2t\n",
      "{'body_text', 'abstract', 'title'}\n",
      "kqntu6ej\n",
      "{'body_text', 'abstract', 'title'}\n",
      "wt4pxu08\n",
      "{'body_text', '12/29', '19/29', '116', 'title', 'abstract', '143', '29/29', 'Supplementary Table 2 | Recombination sites detected from junction-spanning reads.', '137', '238', 'Supplementary Table 5 | Detected modification sites in sgRNAs.', 'Supplementary', '18/29', 'Supplementary Table 3 | TRS-L-dependent recombination events resulting in noncanonical', '105'}\n",
      "0lwmzjxz\n",
      "{'body_text', 'abstract', 'Acknowledgements', 'title'}\n",
      "zfhpij93\n",
      "{'body_text', 'abstract', 'title'}\n",
      "xhnv5cje\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', 'Results', 'Implications for the COVID-19 pandemic', 'Estimating the ascertainment rate in Wuhan'}\n",
      "b49zj5cm\n",
      "{'body_text', 'title', 'abstract', \"Authors' contributions\", 'Funding', 'Declaration of Competing Interest'}\n",
      "ybbnq323\n",
      "{'body_text', 'abstract', 'Conflict of Interest Statement', 'title'}\n",
      "drj3al9t\n",
      "{'body_text', 'abstract', 'title'}\n",
      "o0e6saez\n",
      "{'body_text', 'title', 'abstract', 'FIG. 1. (color online)', 'I(t),'}\n",
      "qgodwdq8\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', 'Acknowledgment', 'Conflicts of Interest', 'The Model', 'Data Availability'}\n",
      "wta7ndnk\n",
      "{'body_text', 'abstract', 'Methods:', 'title'}\n",
      "atnxkvy6\n",
      "{'body_text', 'FAM-AYCACATTGGCACCCGCAATCCTG-BHQ1', 'title', 'abstract', 'ACKNOWLEDGMENTS'}\n",
      "byp9heum\n",
      "{'187', '35', 'title', '13', '15', 'Dynamics of imported and local cases 128', '11', 'Effective reproductive number calculation', '(which was not peer-reviewed)', 'By characterizing the transmission dynamics with quarantine and border control measures across the Chinese 174', '102', 'Dynamics in source regions', '111', '180', 'Figure 2', '42', '14', 'body_text', 'abstract', '112'}\n",
      "66lwpblq\n",
      "{'body_text', 'Patient Classification and Graded Protection', 'Disposal of Anesthetic Items', 'Out of the Operating room Airway Emergencies', 'title', 'Partition Management and Personnel Allocation in the Operating Room for Suspected/Diagnosed Patients', 'abstract', 'Extubation and Anesthesia Recovery', 'Induction of General Anesthesia and Tracheal Intubation', 'Preoperative Evaluation', 'Anesthesia Method', 'How to Identify the Infected Patients', 'ARTICLE IN PRESS'}\n",
      "47goscew\n",
      "{'body_text', 'title', 'The Centers for Disease Control and Prevention (CDC) and World Health', 'abstract', 'Appendix II: Algorithm', '(iii)'}\n",
      "r5niszuj\n",
      "{'body_text', 'abstract', 'title'}\n",
      "b4joa5tx\n",
      "{'body_text', 'In vivo toxicity evaluation of 11a.', 'Preliminary pharmacokinetic (PK) evaluation of 11a and 11b.', 'Antiviral activity assay', 'The crystal structure of SARS-CoV-2 M pro in complex with 11a', 'title', 'abstract', 'The crystal structure of SARS-CoV-2 M pro in complex with 11b', 'Design and synthesis of a series of peptidomimetic aldehydes as coronavirus 3CL protease inhibitors', 'Figure 2. SARS-CoV-2 M pro inhibitor binding pocket for 11a and 11b.', 'Establishing a SARS-CoV-2 M pro activity assay'}\n",
      "vijzfbyj\n",
      "{'body_text', 'title', 'Target the host', 'abstract', 'Target viruses'}\n",
      "kz0qfy3r\n",
      "{'body_text', 'abstract', 'title'}\n",
      "h0q93in1\n",
      "{'body_text', 'U [Phe] C [Ser] U [Phe] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] G [Arg] G [Arg] G [Arg', 'title', 'abstract', 'U [Phe] C [Ser] U [Phe] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] A [Lys] A [Lys] C [Gly]', 'U [Phe] C [Ser] G [Leu] U [Leu] C [Pro] A [Tyr] C [Leu] G [Gly] U [Leu] A [Lys] A [Lys] C [Gly]', 'C [Phe] U [Ser] U [Phe] C [Pro] C [Pro] A [Tyr] C [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]', 'C [Phe] U [Ser] G [Leu] C [Pro] C [Pro] A [Tyr] U [Leu] A [Asp] C [Ser] G [Arg] G [Arg] G [Arg]'}\n",
      "45g12waw\n",
      "{'body_text', 'abstract', '7', 'title'}\n",
      "zaaraiy7\n",
      "{'body_text', 'abstract', 'title'}\n",
      "si1yyg5e\n",
      "{'body_text', 'abstract', 'title'}\n",
      "dm1wkpnv\n",
      "{'body_text', 'abstract', 'Methods', 'title'}\n",
      "qlmp0qul\n",
      "{'body_text', 'Case 3:', 'Case 6:', 'title', 'Case 7:', 'abstract', 'Case 2:', 'Case 8:', 'Case 4:', 'Main text:'}\n",
      "q4u5t8zs\n",
      "{'title', 'Where Surgery is Traditionally Standard of Care, Multidisciplinary and Patient Consideration of Multilevel COVID-19-Specific, Surgery-Specific-Risks and Oncology-Specific Risks of Alternative Therapies', 'Assessment of Multilevel Surgical Risk and Nonsurgical Alternative Therapies', 'Patients', 'Health Care System and Societal Risks', 'Multilevel Surgical Risk Stratification During the COVID-19 Pandemic', 'Providers and Health Care Workers', 'Barriers to Safe Head and Neck Oncologic Surgery', 'Figure', 'Overview', 'COVID-19 Pandemic is Complex Multilevel Risks of Head and Neck Oncologic Surgery', 'Cutaneous, Salivary and Thyroid Malignancies Traditionally Treated with SurgeryPotential Alternatives to Surgery Given the COVID-19 Pandemic and Current Extraordinary Circumstances', 'Primary and Recurrent Mucosal SCCs Traditionally Treated with Surgery', 'body_text', 'Consider a Brief Delay in Surgery if Possible', 'Reevaluation of Head and Neck Oncology Treatment Paradigms', 'abstract', 'COVID-19-Specific Preoperative Planning and Preparation', 'Develop COVID-19-Specific Perioperative Protocols for Head and Neck Oncology Patients'}\n",
      "alsiqv04\n",
      "{'body_text', 'abstract', 'title'}\n",
      "kgkcgpmq\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', '211'}\n",
      "wtdzad90\n",
      "{'body_text', 'abstract', 'title'}\n",
      "w9a0jopu\n",
      "{'body_text', 'abstract', 'title'}\n",
      "6fbnyntq\n",
      "{'body_text', 'abstract', 'Figure. Estimated COVID-19 pediatric hospitalizations (under age 17) in the 13 districts of Wuhan from', 'title'}\n",
      "d1pgjtjh\n",
      "{'body_text', '146', 'title', 'abstract', '154'}\n",
      "a47l7m47\n",
      "{'body_text', 'abstract', 'title'}\n",
      "aa7slcnc\n",
      "{'body_text', 'Supplemental Material', 'ONE STEP REVERSE TRANSCRIPTION DPCR (RT-DPCR)', 'title', 'DYNAMIC RANGE OF THE RT-DPCR ASSAY', 'RT-QPCR', 'abstract', 'COMPARISON ON CLOSE CONTACTS AND CONVALESCENT', \"Authors' Disclosures or Potential Conflicts of Interest: Upon manuscript\", 'ESTABLISHMENT OF LOB AND LOD FOR RT-DPCR ASSAY', 'SPECIFICITY TESTING', 'SUSPECTED PATIENTS', 'LIMIT OF BLANK (LOB) AND DETECTION (LOD) OF RT-DPCR'}\n",
      "vjefplpt\n",
      "{'body_text', 'Vasculitis medications', 'Pathogenesis', 'title', 'abstract', 'Antioxidants', 'Nutritional support', 'Immune modulation', 'FERRET SYSTEMIC CORONAVIRUS-ASSOCIATED DISEASE', 'ACKNOWLEDGMENTS', 'Diagnosis', 'SUMMARY', 'Treatment', 'Clinical Signs'}\n",
      "aeminwf0\n",
      "{'body_text', '12', '10', 'title', '13', 'abstract', '11', 'Derivation of the City Size Dependence of the Reproductive Number', '9', 'Supplementary Figures', '15', '8', '16'}\n",
      "2m6ks6nd\n",
      "{'body_text', 'title', 'abstract', 'Competing interests', 'Ethical approval', \"Contributors' statement\", 'Funding'}\n",
      "6hep2lin\n",
      "{'body_text', 'abstract', '225', 'title'}\n",
      "h7kab2ds\n",
      "{'body_text', 'Figure 1: SARS-CoV-2 PCR threshold cycle values during hospital admission', 'title', 'abstract', 'Declaration of Competing Interests', 'Contributors'}\n",
      "puuqv6zk\n",
      "{'body_text', 'title', 'abstract', 'Funding', 'Declaration of Competing Interest'}\n",
      "u2w2bb2p\n",
      "{'body_text', 'abstract', 'title'}\n",
      "dbowa5bt\n",
      "{'body_text', 'abstract', 'title'}\n",
      "kzudasop\n",
      "{'body_text', 'Table 1', 'title', 'abstract', 'Primers', 'Table 2', 'Conflicts of interest'}\n",
      "2z82hmfh\n",
      "{'body_text', 'Recomendaciones específicas según el tipo de SRNI', 'El Ministerio de Sanidad, Consumo y Bienestar Social de España recomienda adminis-', 'title', 'abstract', 'Estrategia terapéutica del SRNI en el COVID-19', 'COVID-19', 'Antecedentes', 'Ademdum', 'Recomendaciones generales', 'Recomendaciones para la prevención y control de la infección en el paciente sometido a SRNI Objetivo', 'Justificación', 'Ventilacion mecánica no invasiva', 'Elección del tipo de interfase:', 'Resumen'}\n",
      "s4kfza3o\n",
      "{'body_text', 'abstract', 'title'}\n",
      "ub7x9j3d\n",
      "{'body_text', 'abstract', 'title'}\n",
      "oam77j3m\n",
      "{'body_text', '224', '53', '28', '217', '261', 'title', '229', '225', 'abstract', '262', '101', '266', '48', '244', '203', '219', '102'}\n",
      "p5ejn9op\n",
      "{'body_text', 'abstract', 'SARS-CoV-and MERS-CoV-induced immune responses have been studied in', 'title'}\n",
      "1g0mz73b\n",
      "{'body_text', 'abstract', 'title'}\n",
      "bj0pmg6j\n",
      "{'title', '190', '176', '164', '104', '25', '171', '183', '55', '77', '101', '113', '42', '31', 'body_text', 'abstract', '107', '207', '211', '151'}\n",
      "qfj1my37\n",
      "{'Cleaners Wear Approved PPE During Cleaning', 'title', 'Education', 'Staff Monitoring', 'Command and Control', 'Attire', 'Service Segregation', 'Personal Protective Equipment', 'PREVENTING CROSS INFECTION Dedicated Workflows', 'Technology', 'Patient Movement and Coordination', 'Q9', 'Hygiene Measures', 'Distancing Regimens', 'Workload Optimization', 'Staff and Workplace Segregation', 'Staffing', 'Portable Procedures', 'SUMMARY', 'COMMUNICATIONS, COMMAND, AND CONTROL Communication', 'body_text', 'Contact Tracing', 'ROLE OF IR IN COVID-19 PATIENTS', 'abstract', 'PROTECTING PATIENTS Active Screening', 'STAFF MORALE, WELFARE, AND PSYCHOLOGICAL SUPPORT SYSTEMS', 'PRINCIPAL CONSIDERATIONS'}\n",
      "lxegc18n\n",
      "{'body_text', 'Laboratory measures', 'title', 'SARS-CoV-2 and the cytology laboratory', 'abstract', 'Educational measures in academic institutions', 'Use universal precautions. Although it is important to', 'Do', 'Comparison of COVID with other coronavirus outbreaks', 'Communication'}\n",
      "kctgr529\n",
      "{'body_text', 'abstract', 'title'}\n",
      "jmc9yhr0\n",
      "{'body_text', 'Healthcare pressure indications in Europe derived on March 25, 2020', 'Italy as a benchmark for healthcare pressure', 'title', 'abstract', '(which was not peer-reviewed)', 'How do countries compare to Italy?', 'Intensity approach and magnitude approach', 'Healthcare base capacity measures in Europe'}\n",
      "y7lrp0gc\n",
      "{'body_text', 'abstract', 'title'}\n",
      "3ajjzn3o\n",
      "{'body_text', 'title', 'abstract', '178', '242', '240', '230', '41', '69', '216', '60', '145', '253'}\n",
      "hhsa76k8\n",
      "{'body_text', 'abstract', 'SARS-CoV-2 is an appropriate name for the new coronavirus', 'title'}\n",
      "mipdahk4\n",
      "{'body_text', '10', '4', 'Two plots for the main set of parameters, no intervention', 'title', 'abstract', 'Sensitivity to t 2 , the time of lifting the lock-down', '11', 'Values of parameters and generic model', '(which was not peer-reviewed)', 'Main scenarios', '9', 'Sensitivity to R 0', 'Key plots for the main set of parameters, the case with intervention', 'Variables and parameters', 'Figures 4 and 5 similar to'}\n",
      "sozo2a2e\n",
      "{'body_text', '19', 'title', '13', 'abstract', '11', 'Category', 'Fact Checking', 'Human vs non-human classification', 'Figure 2 shows how countries characterized by different levels of infodemic risk present', '17', 'Data collection'}\n",
      "n5kpvsvg\n",
      "{'body_text', 'Cis-cleavage assay', 'Paper Strip Test', 'Trans-cleavage reporter assay', 'title', 'abstract', 'Effects of metal ions on Cas12a cleavage study', 'Biolayer Interferometry (BLI) binding kinetic assay', 'M13mp18 nonspecific cleavage assay', 'DNA activator preparation', 'LbCas12a expression and purification'}\n",
      "423utgpm\n",
      "{'body_text', 'J o u r n a l P r e -p r o o f', 'title', 'abstract', 'Puntos claves de la radiología:', 'Clínica y pruebas de laboratorio:', 'Impacto psicológico:', 'Controles administrativos:', 'Diagnostico microbiológico:', 'SDRA en la infección por SARS-CoV-2', 'Seguridad frente a la pandemia:', 'Tratamiento antiviral', 'El triage de enfermos críticos durante una pandemia:'}\n",
      "8m6793vd\n",
      "{'body_text', '139', 'title', '56', 'abstract', '266', '81', '62', '236', '137'}\n",
      "pn6tu1sm\n",
      "{'body_text', '1.', 'publicada el 19', '2.', 'Manejo de la vía aérea', 'Líquidos y vasopresores', 'title', 'Choque', 'Medidas de prevención generales', 'abstract', 'Finalización del embarazo', 'Consideraciones finales', 'Estudios imagenológicos indicados en COVID-19', 'Enfoque específico para la gestante con infección severa por COVID-19 en UCI', 'Oxigenoterapia y ventilación mecánica', 'Monitorización', 'Enfoque inicial de la gestante como caso sospechoso o confirmado'}\n",
      "2kwfcgz9\n",
      "{'body_text', 'abstract', 'title', 'Funding source'}\n",
      "vmsq5hhz\n",
      "{'title', 'Scenario #9. End of social isolation except for elderly once R0 threshold is reached', 'Model description', 'Scenario #10. End of social isolation once fatality rate threshold is reached', 'Rates of transition between infection stages', 'Scenario #7. Awareness of infection by extensive random testing', 'Impact of dynamic interventions on a COVID19 outbreak case study', 'Scenario #4. Selective social isolation of young and elderly combined', 'Introduction', 'Scenario #6. Increase in personal protective measures', 'Scenario #5. Increase on critical health care resources', 'Impact of static interventions on a COVID19 outbreak case study', 'Modelling interventions', 'Scenario #11. End of social isolation except for elderly once fatality rate threshold is reached', 'Scenario #8. Complete end of social isolation once R0 threshold is reached', 'Roadmap for model expansion and application', 'Scenario #1. Universal social isolation', 'body_text', 'Rates of infection', 'Model limitations', 'Definition Parameter Units', 'abstract', 'Model constituents', 'Reproduction number (R0) and its calculation', 'Scenario #3. Selective social isolation of the young'}\n",
      "si91es0i\n",
      "{'body_text', 'title', 'abstract', \"Authors' contributions\", 'Funding', 'The psychiatric impact of the novel coronavirus outbreak', 'Declaration of Competing Interest'}\n",
      "tf3u6956\n",
      "{'body_text', 'Logistic Considerations', 'Clinical Patient Management and Monitoring', 'title', 'abstract', 'Management Considerations', 'Results', 'Darunavir Ritonavir and Darunavir/Cobicistat', 'Tocilizumab', 'Corticosteroids', 'Patient Flow', 'Remdesivir', 'Chloroquine-Hydroxychloroquine', 'Lopinavir/Ritonavir, Second-Generation Antiretroviral', 'Q6'}\n",
      "3go7thqh\n",
      "{'body_text', 'title', 'abstract', 'Data Availability', 'Ethics'}\n",
      "dpcpg5c1\n",
      "{'body_text', 'abstract', 'title'}\n",
      "osbk041e\n",
      "{'body_text', 'abstract', 'title'}\n",
      "52f5pdw2\n",
      "{'body_text', 'Antiviral Treatments', 'title', 'abstract', 'Preventative Strategies', 'Exploring Current Clinical Trials for Covid-19', 'Race towards a Successful Intervention for Covid-19', 'Immunosuppressants/ Immunomodulators', 'Trends Trends in in Pharmacological Pharmacological Sciences Sciences', 'Global Response', 'Trends in Pharmacological Sciences'}\n",
      "2rc8n3x6\n",
      "{'body_text', 'abstract', '4', 'title'}\n",
      "jmdcf812\n",
      "{'body_text', 'abstract', 'Funding：Not applicable', 'title'}\n",
      "o045bvn7\n",
      "{'body_text', 'High expression genes in host 143', 'title', '10/13', '138', 'abstract', '74', '71', '163', '39', '59', '95', '183', '152', '135', '64'}\n",
      "9ukf9vpg\n",
      "{'body_text', 'abstract', 'title'}\n",
      "9efyzmiz\n",
      "{'body_text', '182', '157', 'title', 'abstract', '46', '59', '88', '83'}\n",
      "p8cmm6ty\n",
      "{'body_text', 'title', 'abstract', 'The exclusion process and medical precautions refer to non-fever patients', 'Summary', 'Funding information', 'Declaration of Competing Interest'}\n",
      "l47noshz\n",
      "{'body_text', 'abstract', 'title'}\n",
      "czpz3yh2\n",
      "{'body_text', 'abstract', 'intervention prevents children, adults and the elderly respectively from getting infected. To ensure intervention strengths (effective reproductive numbers) are comparable between S3-S5, there is always some intervention applied to the adult group. Interventions start 100 days after outbreak start and last for 120 days (black vertical lines). See SM for details on the model and intervention implementation. Note that the model is very simple and only meant to illustrate our conceptual idea, it is not detailed enough to reflect any realistic intervention scenario.', 'title'}\n",
      "8uhjvw7x\n",
      "{'body_text', 'abstract', 'title'}\n",
      "u4di2tk7\n",
      "{'body_text', 'abstract', 'title'}\n",
      "uizdigo0\n",
      "{'body_text', '94', 'title', 'abstract', 'Conflicts of interests', 'Page 6', '(which was not peer-reviewed)', '83', 'Page 11', '96', 'Page 5'}\n",
      "kb3z3b8f\n",
      "{'body_text', '58', '19', '51', '50', 'title', 'abstract', '03', '93', '04', '17'}\n",
      "7v7pzclb\n",
      "{'body_text', 'Figure 1. Assembly of an active nsp12-nsp-7-nsp8 RdRp complex and its inhibition by Remdesivir.', 'Model building and refinement', 'Image processing and 3D reconstruction of the template and Remdesivir bound complex', 'Thermal shift assay (TSA)', 'title', 'Constructs and expression of the RdRp complex', 'abstract', 'Image processing and 3D reconstruction of the apo complex', 'Preparation of template-primer RNA for polymerase assays', 'Purification of the RdRp complex', 'RdRp enzymatic activity assay and its inhibition by Remdesivir-triphosphate and Remdesivir', 'Gel mobility shift assay to detect RNA-RdRp protein binding', 'Cryo-EM data acquisition'}\n",
      "v9h4rlln\n",
      "{'body_text', 'abstract', 'title'}\n",
      "ag0s2u1t\n",
      "{'body_text', 'abstract', 'title', 'Comment [COMP1]:'}\n",
      "lm2ixz8n\n",
      "{'body_text', 'abstract', 'title'}\n",
      "yw81pkrq\n",
      "{'139', 'title', '257', '192', '205', '299', '202', '(which was not peer-reviewed)', '289', '311', '39', '50', '279', '231', '42', '167', '195', '256', 'body_text', '229', '259', '134', '232', 'abstract', '211', '238', '169'}\n",
      "yj2jh694\n",
      "{'body_text', 'Demographic information', 'title', 'Conflict of Interest', 'Regression analysis results of emotional responses and coping strategies', 'abstract', 'Coping strategies', 'Correlation between emotional responses and coping strategies', 'Statistical analyses', 'Emotional responses', 'Ethical Approval', 'General situations and difference of emotional responses and coping strategies'}\n",
      "ouyr4oke\n",
      "{'body_text', 'Name', 'title', 'RTX polymerase-based TaqMan qRT-PCR reaction set up', 'abstract', 'Resuspension'}\n",
      "y3ia8g3h\n",
      "{'body_text', 'abstract', 'title'}\n",
      "el1vyyj9\n",
      "{'body_text', 'abstract', 'title'}\n",
      "8u7d4czd\n",
      "{'body_text', 'Materials & Method:', '2-TEOAE:', 'title', 'abstract', 'Acknowledgements:', 'Results:'}\n",
      "t9bt70f2\n",
      "{'body_text', 'abstract', 'Main Text:', 'title'}\n",
      "q75gmr30\n",
      "{'body_text', 'title', 'abstract', 'Data availability', 'Consent for publication', \"Authors' contributions\", 'Author statement', 'Funding', 'Dear editor,', 'Declaration of Competing Interest'}\n",
      "wb19vqv3\n",
      "{'body_text', 'Phylogenetics', 'Diagnostics and sequencing', 'Acknowledgments', 'title', 'abstract', 'Dynamical modeling', 'Disclaimer', 'Main text', 'Ethics Approval'}\n",
      "t6blhwy2\n",
      "{'body_text', 'title', 'abstract', 'Teamwork and virtual meetings', 'Medical offices, elective surgeries and urgencies'}\n",
      "e6q92shw\n",
      "{'body_text', 'title', 'abstract', '11', 'Methods', 'Deployment.'}\n",
      "vpmrwanr\n",
      "{'body_text', 'title', 'abstract', \"Authors' contributions\", 'To editor,', 'Declarations of Competing Interest'}\n",
      "b4kzgubs\n",
      "{'body_text', 'abstract', '5/218 (see comments)', 'title'}\n",
      "jnp2ldcj\n",
      "{'body_text', 'Table 1. Proposed protective mechanisms of ARB administration in 2019-nCoV infection', 'J o u r n a l P r e -p r o o f', 'title', 'abstract', 'In agreement with the Position Statement of the ESC Council on Hypertension on ACE Inhibitors and Angiotensin Receptor Blockers'}\n",
      "7e8zlt3t\n",
      "{'body_text', 'abstract', 'title'}\n",
      "hng8ivz2\n",
      "{'body_text', '6', 'title', 'abstract', '4 6', '3 9', '8'}\n",
      "rgtv9t84\n",
      "{'body_text', 'abstract', 'title', 'Role of temperature and relative humidity 155'}\n",
      "penb65x7\n",
      "{'body_text', 'abstract', 'Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel', 'title'}\n",
      "6kuigenh\n",
      "{'body_text', 'abstract', 'COVID-19 control in China during mass population movements at New Year', 'title'}\n",
      "gb9rkv9c\n",
      "{'body_text', 'title', 'abstract', 'Data 113', '170', '111', '71', 'necessary. 55'}\n",
      "1e28zj1d\n",
      "{'body_text', 'abstract', 'title'}\n",
      "wlat2rrl\n",
      "{'body_text', 'COVID-19 and pre-existing liver disease', 'Reprocessing of endoscopes and endoscopic accessories:', 'title', 'abstract', 'COVID-19 and pre-existing digestive diseases', 'COVID-19 in the endoscopy unit', 'COVID-19 and the liver', 'COVID-19 and the gastrointestinal tract'}\n",
      "94sg088l\n",
      "{'body_text', 'The role of Specialist Palliative Care in COVID-19:', 'Management of delirium:', 'title', 'Patient with pre-existing renal failure:', 'abstract', 'Summary:', 'Key words:', 'Introduction:', 'Abstract:', 'Palliative Care Pandemic Pack -a tool for guiding non-palliative care clinicians:', 'Management of respiratory secretions:', 'Guidance for clinicians:', 'Guidance for organisations:', 'Management of dyspnea', 'The Waikato DHB context:'}\n",
      "4faxpgia\n",
      "{'body_text', 'abstract', 'Box 1 MG-Related Factors that Contribute to Pandemics', 'title'}\n",
      "mt8h4rk5\n",
      "{'body_text', 'Comparison of transmissibility with SARS and MERS', 'Epidemic size estimates', 'Transmission model', 'Abstract', 'title', 'Epidemiological parameter estimates', 'abstract', 'Limitations', '(which was not peer-reviewed)', 'Domestic and international connectivity of Wuhan', 'Summary', 'Comparison of estimates to other reports', 'Background and current epidemic situation'}\n",
      "kp2ewbn1\n",
      "{'body_text', 'abstract', 'title', 'Conflicto de intereses'}\n",
      "3khv6yrc\n",
      "{'body_text', 'abstract', 'title', '▪'}\n",
      "aul6ahww\n",
      "{'body_text', 'abstract', 'Funding Source', 'title'}\n",
      "ha110a72\n",
      "{'body_text', 'abstract', 'title'}\n",
      "5n1847is\n",
      "{'body_text', 'title', '232', 'abstract', '212', '240'}\n",
      "gs0apie5\n",
      "{'body_text', 'title', 'abstract', 'Case Definitions', 'Data and Test'}\n",
      "brteb985\n",
      "{'body_text', 'abstract', '*Clare Wenham, Julia Smith, Rosemary Morgan, on behalf of the Gender and COVID-19 Working Group † c.wenham@lse.ac.uk', 'title'}\n",
      "dtuk7gfv\n",
      "{'body_text', 'title', 'abstract', 'Abstract:', '19.', 'Main text:'}\n",
      "plh92ifi\n",
      "{'Protease inhibitor treatment', 'Primary cell preparation for flow cytometry', 'VSV pseudoparticles', 'title', 'HCoV-229E-Rluc infection assay of KO cells', 'Spike cleavage assays.', 'Viral infection assays', 'Generation of recombinant VSV vector driving CoV S protein expression (VSV*∆G(CoV))', 'Materials & Correspondence', 'Split luciferase fusion assay', 'Acknowledgements', 'Mice', 'Binding experiment', 'RNA extraction and RT-qPCR', 'RNA isolation from primary tissues', 'Multiple Sequence alignment and phylogeny', 'Syncytia formation assay', 'ISG screen.', 'body_text', 'RNA library construction and sequencing', 'Statistical analysis', 'abstract', 'Data availability', 'Competing interest declaration', 'In vivo infection, viral titers, liver ALT, and liver histology', \"Mantel-Cox test (a), two-tailed unpaired student's t-test with Welch's correction (c-e, i-k), two-tailed\"}\n",
      "tzdgc3dw\n",
      "{'body_text', 'abstract', '(which was not peer-reviewed)', 'title'}\n",
      "44ji0g78\n",
      "{'body_text', 'abstract', 'title'}\n",
      "gfjpsduv\n",
      "{'body_text', 'abstract', 'Author contributions', 'title'}\n",
      "71b6ai77\n",
      "{'body_text', 'abstract', 'title', 'Figure 1. Trend in City Mobility Index (CMI) in 41 cities compared to baseline'}\n",
      "f4hj35dr\n",
      "{'body_text', 'Materials and Methods', 'title', 'abstract', 'Acknowledgements.', 'iv) Low levels of cross immunity from the other betacoronaviruses against SARS-CoV-2'}\n",
      "prqeufwg\n",
      "{'body_text', '2019-nCoV S prompted us to test published SARS-CoV RBD-directed monoclonal antibodies 105', 'title', 'abstract', 'Protein expression and purification 122', 'Biolayer interferometry 186', 'Surface plasmon resonance 167', 'Cryo-EM data processing 157', 'Negative stain EM 177'}\n",
      "ejgr63n4\n",
      "{'body_text', 'abstract', 'title', 'As coronavirus cases increase and deaths surge in Italy, new figures show an'}\n",
      "o349msnm\n",
      "{'body_text', 'abstract', 'title'}\n",
      "p2u809yz\n",
      "{'body_text', 'abstract', 'title'}\n",
      "cxktdaws\n",
      "{'body_text', 'title', '43', 'abstract', '42', '31'}\n",
      "8vtz7owc\n",
      "{'body_text', 'Transmissibility of 2019-nCoV', 'Pathogenicity of 2019-nCoV', 'title', 'abstract', 'Relationship between viral pathogenicity and transmissibility', 'Declaration of Competing Interest'}\n",
      "tjsw205c\n",
      "{'225', '155', 'title', '60', '5/19', '92', '12/19', '72', '13/19', '11/19', '101', '163', '189', '88', '167', '7/19', 'body_text', '217', 'abstract', '3/19', '173', '8/19', '122'}\n",
      "fe8a2bnc\n",
      "{'body_text', 'SARS-CoV 3a was incorporated into virus-like particles in insect cells co-infected with recombinant baculoviruses expressing the E, M, and 3a', 'title', 'abstract', 'SARS-CoV 3a was secreted into the culture supernatant of infected Vero E6 cells and was incorporated into virions', 'Materials and methods'}\n",
      "lioj0tkn\n",
      "{'body_text', 'COVID-19 Daily questionnaire', 'title', 'abstract', 'Figure 4:'}\n",
      "1fyag5x3\n",
      "{'body_text', 'abstract', 'title'}\n",
      "030bc0h3\n",
      "{'body_text', 'abstract', 'title'}\n",
      "6om1y33o\n",
      "{'body_text', '357', '306', 'title', 'abstract', '326', '324', '342', '286', '341', '464', '256'}\n",
      "cjcxcsx5\n",
      "{'body_text', '35', 'title', 'abstract', '5'}\n",
      "5f42du0b\n",
      "{'body_text', 'abstract', 'title'}\n",
      "edu1zuzt\n",
      "{'body_text', 'abstract', '87', 'title'}\n",
      "qyh1vkgi\n",
      "{'body_text', 'Originn of Connennun Statement', 'Annumptonn', 'Procenn of priority ntatun determinaton for individual patentn', 'title', 'abstract', 'Final Thought', 'Shared Decinion Making and Trannparency', 'Appendix of Contributng Authorn in alphabetcal order:'}\n",
      "dl6rbqxp\n",
      "{'body_text', '. The World Health', 'Tissue Cultures and Virus', 'Reversal correlation', 'title', 'abstract', 'Clustering of virus predictions', 'Gene Ontology (GO) Enrichment Analysis', 'Ritonavir correlation analysis', 'Main', 'Software tools and statistical methods', 'Drug screening by cell-based assay', 'Disease signatures', 'Data and code availability'}\n",
      "exoc6xvt\n",
      "{'body_text', '319', '75', '306', 'title', 'abstract', '316'}\n",
      "2rf9l55q\n",
      "{'body_text', 'abstract', 'title'}\n",
      "sjod3q3j\n",
      "{'body_text', 'abstract', 'title'}\n",
      "qgvue8yw\n",
      "{'body_text', 'abstract', 'Dynamic analysis of ELISA and RT-PCR assays', 'title'}\n",
      "vvhhpchm\n",
      "{'body_text', '2019', 'Box 2 | Identifying viral species', 'title', 'Middle East respiratory syndrome-related coronavirus', 'abstract', 'SARS-CoV-2 versus SARS-CoV distances', 'SARS-CoV-2 SARS-CoV', 'expanding the focus from pathogens to virus species', 'Box 3 | Classifying coronaviruses', 'Classifying and naming viruses and virus species', 'Box 4 | Classifying SARS-CoV-2', 'Defining the place of SARS-CoV-2 within the Coronaviridae'}\n",
      "8eh90ber\n",
      "{'body_text', 'abstract', 'title', 'Declaration of Competing Interest'}\n",
      "89s17ytr\n",
      "{'body_text', 'Supplemental Figure 4', '232', 'title', 'abstract', '275', '286', 'Supplemental Figure 3', 'Supplemental Figure 2'}\n",
      "auu02ibd\n",
      "{'body_text', 'abstract', 'title'}\n",
      "zio8yhuy\n",
      "{'body_text', 'title', 'abstract', 'Care of mother and newborn', 'COVID-19', '(which was not peer-reviewed)', 'Infant feeding', 'DELIVERY AND POSTNATAL', 'MERS Three pregnancy losses were reported:', 'RESULTS'}\n",
      "e0bp8cuj\n",
      "{'body_text', 'abstract', 'title', 'Figure Legend.'}\n",
      "fnj57b0l\n",
      "{'body_text', 'abstract', 'title'}\n",
      "7umn0vkv\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', '22, 2020) can be regarded as a free propagation stage of COVID-19 because most'}\n",
      "5xki1ulf\n",
      "{'body_text', 'Background', 'title', 'abstract', '98'}\n",
      "s5215641\n",
      "{'body_text', 'abstract', 'title'}\n",
      "mmkrwj8t\n",
      "{'body_text', '356', 'title', 'abstract', 'MERS-CoV induces a membrane network of modified membranes that contains'}\n",
      "e5iitjwy\n",
      "{'body_text', 'abstract', 'title'}\n",
      "mrgw2mnx\n",
      "{'body_text', 'Influenza viruses. Influenza virus strains used in this study include', 'Barrier function assessment.', 'Repurposing of existing drugs as potential anti-influenza therapeutics', 'CoV2pp infection of human lung Airway Chips. To measure infection in human', 'Mucus quantification. Mucus present in the airway channel was isolated by', 'title', 'Identification of approved drugs with pseudotyped SARS-CoV2 inhibiting activities', 'abstract', 'Supplementary Figure Legends', 'Statistical analysis.', 'Recruitment of circulating immune cells, such as neutrophils, under dynamic flow', 'CoV-2 virus into cells 14 .', 'Recapitulation of the effects of clinically used anti-viral therapeutics', 'Analysis of cytokines and chemokines. Vascular effluents from Airway Chips', 'Fig. S6. Evaluation of the cytotoxicity of test drugs in Huh-7 cells. Huh-7 cells', 'Influenza infection and immune responses replicated in human Airway Chips', 'Analysis of cleavage of virus hemagglutinin (HA) by serine proteases.'}\n",
      "jh04b55m\n",
      "{'body_text', 'abstract', 'title'}\n",
      "g0vyzsga\n",
      "{'body_text', 'Study Population and Data Collection', 'title', 'Chest CT Protocols and Evaluation', 'abstract', 'Statistical Analysis', 'RT-PCR for SARS-CoV-2', 'Table S6. Demographics and baseline characteristics of the subset of patients included in the analysis of CT within the first week after symptom onset', 'Radiographic Findings and other Predictors in Adults with Covid-19', 'Author Contributions'}\n",
      "tuzmu7p5\n",
      "{'body_text', 'abstract', 'title', 'Declaration of Competing Interest'}\n",
      "a5x5ga60\n",
      "{'body_text', '136', '127', 'Median (IQR)', 'title', 'abstract', '(which was not peer-reviewed)', 'Blood routine', '276'}\n",
      "0terogjm\n",
      "{'body_text', 'abstract', 'title'}\n",
      "99doz9m6\n",
      "{'body_text', 'Vaccines', 'title', 'Frequent symptoms', 'abstract', 'Case fatality rate', 'Incubation period', 'Duration of the disease', 'Therapies', 'Basic reproductive number', 'Severe clinical presentations', 'Immunity duration', 'Virus environmental persistence', 'Virus mutation rate and adaptation'}\n",
      "4p6fcy8f\n",
      "{'body_text', 'abstract', 'title'}\n",
      "ewvdl06h\n",
      "{'body_text', 'title', 'abstract', 'Protein-RNA interaction prediction 413 414', '159', '188'}\n",
      "si7csqr2\n",
      "{'body_text', 'abstract', 'title', 'Perspective'}\n",
      "vw4vul5j\n",
      "{'body_text', 'abstract', 'title', 'Contributors'}\n",
      "fy3aet57\n",
      "{'body_text', 'Pathophysiology of COVID-19.', 'title', 'Studies in mice, with LPS-induced lung injury have shown that capsazepine (a TRPV1', 'abstract', 'Resiniferatoxin (RTX) potential to lessen impact of COVID-19 progression.', 'Afferent innervation, TRPV1 channel and inflammation in the lungs.', 'Rationale for blocking afferent signaling (TRPV1) in COVID-19 patients:'}\n",
      "bawgldfi\n",
      "{'306', 'title', '125', '308', 'Number of Occurrences', '157', '542', '68', '219', '209', '304', '230', '194', 'body_text', '134', 'abstract', '213', '208', 'MATERIALS AND METHODS'}\n",
      "i5jk0407\n",
      "{'body_text', 'title', 'abstract', '36', '89', '128', '71', '81', '91'}\n",
      "5lauop7l\n",
      "{'body_text', '204', '380', 'title', 'abstract', '158', '242', '371', '111', '103', '315', '289', '174', '150', 'Supporting information', '341', '66'}\n",
      "wwdlqd98\n",
      "{'Recomendación 3: vigila estrechamente los efectos adversos e interacciones de los fármacos usados ente el SARS-CoV-2.', 'Recomendación 3: no abstraerse de un enfoque territorial en la atención del paciente crítico con COVID-19.', 'GRUPO DE TRABAJO DE PLANIFICACIÓN, ORGANIZACIÓN Y GESTIÓN', 'title', 'GRUPO DE TRABAJO DE TRANSPORTE CRÍTICO', 'Recomendación \"3: no entrar en contacto con el paciente sin el EPI adecuado a cada paciente y situación según el protocolo de cada centro.', 'Medicina Intensiva (SMI) integrado en el plan de contingencia local.', 'Recomendación 2: inicia tratamiento antibiótico empírico hasta descartar la posibilidad de coinfección bacteriana.', 'COVID-19, incluye causas estructurales, infecciosas y vasculares.', 'Recomendación 1: asegura una documentación clínica adecuada pese a insuficiente disponibilidad de recursos asistenciales.', 'GRUPO DE TRABAJO DE CUIDADOS INTENSIVOS NEFROLÓGICOS', 'GRUPO DE TRABAJO DE ENFERMEDADES INFECCIOSAS Y SEPSIS', 'Recomendación 3: no excluir en los registros los pacientes críticos atendidos fuera de la UCI.', 'GRUPO DE TRABAJO DE DONACIÓN Y TRASPLANTES', 'Recomendación 1: no demorar las terapias de depuración extracorpórea.', 'Conflicto de intereses', 'Recomendación 2: monitoriza estrechamente la función renal.', 'Recomendación 2: no desatender las recomendaciones de otras sociedades científicas que han sufrido la crisis anteriormente o con experiencia en situaciones semejantes.', 'Recomendación 3: elabora un plan de actuación que incluya coordinación con centro de referencia, así como traslados intrahospitalarios.', 'Recomendación 1: no administrar amiodarona junto con cloroquina darunavir o lopinavir/ritonavir por alto riesgo de efectos adversos.', 'B-Recomendaciones \"No hacer\".', 'Recomendación 2: la reanimación cardiopulmonar en COVID-19 se debe iniciar solo con compresiones, analizar el ritmo y es imprescindible mantener el equipo de protección individual (EPI).', 'COVID-19 en su evolución a largo plazo.', 'Recomendación 1: obtén muestras nasal y faríngea o del tracto respiratorio inferior en el caso de pacientes intubados para realizar la reacción en cadena de la polimerasa (PCR) de SARS-CoV-2.', 'Recomendación 3: no participará personal no esencial en la asistencia a pacientes con trauma grave o neurocríticos.', 'Recomendación 1: la evaluación de pacientes con trauma grave o neurocrítico debe efectuarse tomando las medidas adecuadas.', 'body_text', 'abstract', 'Recomendación 1: no exponer innecesariamente al personal de la UCI.', 'GRUPO DE TRABAJO DE TRANSFUSIONES Y HEMODERIVADOS', 'Recomendación 2: no iniciar soporte ECMO sin estudio ecocardiografico previo para valorar la función cardiaca.', 'Recomendación 2: no efectuar pruebas complementarias que impliquen desplazamientos del paciente traumático o neurocrítico con COVID-19 y que no vayan a suponer cambios sustanciales en la actitud terapéutica.', 'GRUPO DE TRABAJO DE SIMULACIÓN', 'GRUPO DE TRABAJO DE NEUROINTENSIVISMO Y TRAUMA', 'Recomendación 1: no dejar de cumplir los protocolos de prevención de infección relacionada con la asistencia sanitaria en UCI (Proyectos Zero).', 'METODOLOGÍA DE LA INVESTIGACIÓN'}\n",
      "zrbesm5b\n",
      "{'body_text', 'abstract', 'title'}\n",
      "1mpzjgk1\n",
      "{'body_text', 'abstract', 'title'}\n",
      "ti9b1etu\n",
      "{'body_text', 'Procedures', 'title', 'Statistical analysis', 'abstract', 'Real-Time reverse transcription polymerase chain reaction assay', 'C100(brother)', 'Control measures in China and current status in two centers', 'Study population', 'Ethics approval', 'Transmission characteristics of 104 patients', 'CT imaging findings of two discharged patients of serious conditions', 'Clinical characteristics and medical treatment of 104 cases', 'Hunan'}\n",
      "t2x4yfrv\n",
      "{'body_text', 'Prediction for infection rate and state variables 301', '18', '19', '172', '307', 'title', '51', '258', 'abstract', '284', '11', '297', '222', '275', '20', '209', '256'}\n",
      "v9fdn4uu\n",
      "{'body_text', 'abstract', 'title'}\n",
      "p8aa2y6c\n",
      "{'body_text', 'abstract', 'title', 'Results 123'}\n",
      "xs7vkm19\n",
      "{'body_text', 'title', 'Personal Items', 'abstract', 'Air Samples', 'Methods', 'Room Surfaces'}\n",
      "ssdx8xwi\n",
      "{'body_text', '120', '132', '261', 'title', 'abstract', '170', '100', '112', '84', '374', '276', '290', '366'}\n",
      "vf5gftxb\n",
      "{'body_text', '77', '229', '277', 'title', '43', 'abstract', '178', '165', '197', '100', '113', '59', '81', '199', '169', '122'}\n",
      "n10abfvd\n",
      "{'body_text', '4', 'title', 'abstract', '(which was not peer-reviewed)', 'Model', 'Results'}\n",
      "0y70ae8o\n",
      "{'body_text', 'abstract', 'title'}\n",
      "jljjqs6m\n",
      "{'body_text', '10', 'Original article', 'title', '13', 'abstract', '5', '9', '95% Confidence Interval Exponent', '15', '8'}\n",
      "5qbsmyjb\n",
      "{'body_text', 'title', 'abstract', 'CONTROL SYSTEM AND OPERATION', 'INTRODUCTION', 'DESIGN AND COMPONENTS'}\n",
      "dqxfcwyu\n",
      "{'body_text', '217', 'title', 'Figures and', 'abstract', '79', '89', '214', '173', '151', '129'}\n",
      "7en6cog7\n",
      "{'body_text', 'title', '99', 'abstract', '83', '52', '57'}\n",
      "aeuy92bx\n",
      "{'body_text', 'Cell Fusion Inhibition Assay.', 'title', 'abstract', 'Affinity measurement', 'Pseudovirus Neutralization Assay.', 'Conflicts of interest', 'Generation of fusion proteins', 'Pharmacokinetics'}\n",
      "ophojm43\n",
      "{'body_text', 'abstract', 'title'}\n",
      "zicat4qp\n",
      "{'body_text', 'title', 'abstract', 'Statistical Analysis', 'Results', 'Data collection'}\n",
      "7eokrk78\n",
      "{'body_text', 'abstract', 'I. THE COVID-19 BURDEN INDEX', 'title'}\n",
      "qpaig5tm\n",
      "{'body_text', 'title', 'abstract', '76', '128'}\n",
      "87g7g5au\n",
      "{'SIGNIFICANCE AS PUBLIC HEALTH PROBLEM AND POTENTIAL AS BIOTHREAT AGENT', 'title', 'Inactivated Whole Virus and Subunit Vaccines', 'INTRODUCTION', 'PATHOGENESIS', 'VACCINES', 'HUMORAL IMMUNE RESPONSE', 'CELLULAR IMMUNE RESPONSE', 'TREATMENT', 'EPIDEMIOLOGY', 'KEY ISSUES', 'CLINICAL TRIALS', 'CLASSIFICATION AND ANTIGENS ENCODED', 'INNATE IMMUNE RESPONSE TO INFECTION', 'PROSPECTS FOR THE FUTURE', 'body_text', 'abstract', 'POSTEXPOSURE IMMUNOPROPHYLAXIS', 'PRECLINICAL DEVELOPMENT, INCLUDING RELEVANT ANIMAL MODELS', 'ETIOLOGIC AGENT', 'CLINICAL DISEASE', 'BASIC SCIENCE AND RATIONALE OF NEW GENERATION VACCINES', 'Vectored Vaccines'}\n",
      "0pg3uylx\n",
      "{'body_text', \"Pour le cancer de l'ovaire\", 'title', 'Pour les cancers de la vulve', 'abstract', 'Pour le cancer du vagin', 'Le suivi post-thé rapeutique', 'Pour les tumeurs trophoblastiques', 'Pré ambule', \"Pour une suspicion de cancer de l'endome`tre\", \"Dé claration de liens d'inté rêts\", 'Pour le cancer du col', 'Prise en charge des patientes atteintes de cancer pelvien'}\n",
      "q4m2uj6r\n",
      "{'body_text', '50', 'title', '54', 'abstract', '106', 'Quantification of SARS-CoV-2 RNA', '112'}\n",
      "hj675z1b\n",
      "{'body_text', 'title', 'abstract', \"Fig. 4 | Incorporation of 2'-F,Me-UTP, 3'-F-dTTP and 3'-N 3 -dTTP by SARS-CoV RdRp to terminate the polymerase reaction.\", \"Fig. 3 | Incorporation of 2'-F,Me-UTP by two low-fidelity polymerases as terminators but not by a high-fidelity polymerase.\"}\n",
      "ailr08y5\n",
      "{'body_text', 'Introducción', 'Origen', '¿A quién notificar cuando existe sospecha de infección o casos confirmados?', 'title', 'Medidas de prevención', 'abstract', 'Pruebas clínicas para el diagnóstico', 'Características estructurales de los coronavirus', 'Cuadro clínico', 'Tratamiento', 'Conclusión', 'Clasificación de los pacientes de acuerdo con sus síntomas clínicos', 'Conflicto de intereses'}\n",
      "uz91cd6h\n",
      "{'body_text', 'Figure 2. Maximum-likelihood phylogenetic tree constructed based on 50 SARS-CoV-2 genomes in this study and genomes collected from GISAID data hub', 'Orf1ab', 'title', '1', 'abstract', '5', '5 9', '5 6', 'Figure 3. Maximum-likelihood phylogenetic tree of the 50 COVID-19 cases in this study', '2 6', '5 0'}\n",
      "0d6o5w8z\n",
      "{'body_text', '12', '18', 'title', 'abstract', '9'}\n",
      "ua0luq11\n",
      "{'body_text', 'abstract', '130', 'title'}\n",
      "orqlbw9m\n",
      "{'body_text', 'Cell Host & Microbe', 'title', 'abstract', 'SUPPLEMENTAL INFORMATION'}\n",
      "ixun0c8g\n",
      "{'body_text', 'Antiviral activities of baicalin and baicalein in cells', 'The inhibition assay of SARS-CoV-2-3CLpro', 'Protein-ligand binding supported by ITC and ESI-MS', 'Protein expression and purification', 'title', 'Fig. 3. Antiviral activities of baicalin and baicalein against SARS-CoV-2 in Vero E6 cells. (A and B) Cytotoxicity of baicalin (A) or baicalein (B) to Vero E6 cells was measured by CCK', 'abstract', 'Inhibition of SARS-CoV-2 3CLpro by baicalin and baicalein', 'Unique binding mode of baicalein with SARS-CoV-2 3CLpro', 'Protein crystallization and structure determination', 'Competing interests', 'Separation of S. baicalensis extract', 'The cell-based antiviral activity assay', 'Crystal structure of SARS-CoV-2 3CLpro in complex with baicalein', 'Figures S1-S4', 'Isothermal titration calorimetry (ITC) measurements', 'Data availability statements'}\n",
      "1vm5r7pq\n",
      "{'body_text', 'Glucocorticoids', 'title', 'abstract', 'Tocilizumab treatment of CS', 'Mimicry of vasculitis and thrombosis are prominent features in severe COVID-19 patients', 'The immune system was impaired in critical COVID-19 patients', 'Inflammatory cytokine storm was very common in patients with severe COVID-19', 'JAK inhibitors', 'Current knowledge of anti-inflammation treatment in COVID-19 patients', 'Chloroquine and hydroxychloroquine', 'Declaration of Competing Interest'}\n",
      "0yqyclxk\n",
      "{'body_text', 'Structure-based B-cell epitopes prediction 162', 'Molecular docking analysis of T-cell epitopes with HLA alleles 229', 'title', 'Prediction of mRNA secondary structure of the CoV-RMEN 378', 'Linear B-cell epitopes prediction 572', 'abstract', 'Immune simulation 690', 'Immune simulation 328', 'Sequence retrieval and structure generation 544', 'Screening for T-cell epitopes 592', 'IFN-γ inducing epitope prediction 241', 'Expression of CoV-RMEN with SUMO-fusion 387', 'Secondary and tertiary structures prediction of the CoV-RMEN 302', 'Recognition of T-cell epitopes 206'}\n",
      "qefiw4ho\n",
      "{'body_text', 'abstract', 'title'}\n",
      "pobmam24\n",
      "{'body_text', 'Human samples 237', 'title', 'Differential expression analysis 295', 'abstract', 'COVID-19 patients. 171', 'Data Availability 339'}\n",
      "r1a2zwj4\n",
      "{'body_text', 'Modeling the effect of testing, isolation and social protection of infected individuals', 'Sustainable social distancing through facemask use and testing during the Covid-19 pandemic', 'title', 'abstract', 'Reproduction number with testing, isolation, and social protection'}\n",
      "iy4knx7j\n",
      "{'body_text', 'Epitope Designing', 'title', 'abstract', 'Protein Structural Alignment', 'Glycosylation and structural modification', 'Analysis for Epitopes binding efficiency to MHC Class II', 'Antigenecity Prediction', 'Molecular Docking', 'Effect of epitope glycosylation on MHC class IIepitope binding', 'Analysis of epitope binding to specific MHC Class II', 'Secondary structure analysis', 'Conserved Motif Identification', 'Structure Prediction and Structure Quality Assessment', 'COVID 19 specific Epitope Designing', 'Sequence Comparison'}\n",
      "x22rc60j\n",
      "{'body_text', '418', 'title', 'abstract', '373', '88', '334'}\n",
      "5wsj003j\n",
      "{'body_text', 'Funding 237', 'title', 'abstract', '88', 'Data analysis 151', 'Informed consent 247', 'Acknowledgements 249', 'Ethical approval 243', 'Conflict of interest 240'}\n",
      "v8k2898q\n",
      "{'body_text', 'abstract', 'title'}\n",
      "dxiyqf9d\n",
      "{'body_text', 'abstract', 'title'}\n",
      "n0ieojnp\n",
      "{'body_text', 'Spécificité de la prise en charge des cancers oesogastriques Synthèse', \"Déclaration de liens d'intérêts\", 'title', 'abstract', 'Spécificité de la prise en charge par type de cancers', \"Stratégie pour la pratique de la chirurgie digestive oncologique en situation d'épidémie de COVID-19\", \"Stratégie globale pour la pratique de la chirurgie viscérale en situation d'épidémie de COVID-19\", 'Adaptation du système de consultation', 'Synthèse', 'Financement', \"Impact oncologique du délai d'attente\", 'Adaptation de la période postopératoire', 'Morbi-mortalité'}\n",
      "wfh9pzb2\n",
      "{'body_text', 'abstract', 'rpeckham@hku.hk', 'title'}\n",
      "zrgax3qa\n",
      "{'body_text', 'title', 'Methodology', 'abstract', '(which was not peer-reviewed)', 'Final considerations:'}\n",
      "lhv83zac\n",
      "{'body_text', 'title', 'abstract', '(which was not peer-reviewed)', '5.', 'Simulation 3.'}\n",
      "dl45plby\n",
      "{'body_text', 'abstract', 'title'}\n",
      "4sw1hrnf\n",
      "{'body_text', 'Basic reproduction number, R0', 'title', 'References', 'abstract', 'Modeling the effect of testing and treatment/isolation of individuals', 'Susceptible individuals may be infected by contacting symptomatic and infectious individuals (Is+ In) and partially infectious individuals incubating the disease (E). The force of infection is', 'Modeling the time to get to zero', 'Modeling the effect of vaccination'}\n",
      "mgp38mdz\n",
      "{'body_text', 'title', 'abstract', 'Ortiz-Perez et al. 27', 'Li et al. 19', 'Ramchand et al., 30', 'Uri et al., 28', 'Source Study Details Effect of ACEI / ARB on ACE2'}\n",
      "jalijjmg\n",
      "{'body_text', 'title', '125', 'abstract', '98'}\n"
     ]
    }
   ],
   "source": [
    "for uid in uid_sect_header_artifacts['uids_with_body_text']:\n",
    "    print(uid)\n",
    "    print(uid_section_headers_dict[uid])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 302,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/slander/anaconda3/lib/python3.7/site-packages/pandas/core/indexing.py:576: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  self.obj[item_labels[indexer[info_axis]]] = value\n",
      "/home/slander/anaconda3/lib/python3.7/site-packages/ipykernel_launcher.py:12: UserWarning: DataFrame columns are not unique, some columns will be omitted.\n",
      "  if sys.path[0] == '':\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "As a starting point, convert the covid19_df (metadata filtered to covid-19 papers) into a dict with title and abstract sections.\n",
    "\n",
    "\"\"\"\n",
    "\n",
    "\n",
    "covid19_df_copy = covid19_df.copy()\n",
    "covid19_df_copy = covid19_df_copy.set_index('cord_uid')\n",
    "covid19_title_abstract_df = covid19_df_copy[['title', 'abstract']]\n",
    "covid19_title_abstract_df.loc[:, 'title'] = covid19_title_abstract_df.loc[:, 'title'].str.lower()\n",
    "covid19_title_abstract_df.loc[:, 'abstract'] = covid19_title_abstract_df.loc[:, 'abstract'].str.lower()\n",
    "covid19_title_abstract_dict = covid19_title_abstract_df.transpose().to_dict()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 303,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing resources/v8_preprocessed/v8processedText1.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText4.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText8.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText10.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText3.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText0.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText12.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText15.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText2.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText6.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText19.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText18.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText11.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText13.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText5.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText7.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText17.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText16.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText14.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n",
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n",
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n",
      "Extracting 3 Discussion and conclusion section...\n",
      "Processing resources/v8_preprocessed/v8processedText9.parquet...\n",
      "Extracting Conclusions section...\n",
      "Extracting Action plan and discussion section...\n",
      "Extracting Discussion section...\n",
      "Extracting Conclusion section...\n",
      "Extracting CONCLUSION section...\n",
      "Extracting Discussion: section...\n",
      "Extracting Conclusion remarks ::: Introduction section...\n",
      "Extracting 11. Conclusion section...\n",
      "Extracting Concluding remarks section...\n",
      "Extracting Conclusion. :::  section...\n",
      "Extracting (iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? :::  section...\n",
      "Extracting Conclusion and future prospects section...\n",
      "Extracting Closing remarks section...\n",
      "Extracting RESULTS AND DISCUSSION section...\n",
      "Extracting Conclusion ::: Low-dose steroids and NSAIDs ::: Results section...\n",
      "Extracting Conclusion ::: Mycophenolate ::: Results section...\n",
      "Extracting Conclusion ::: IL-6 blockade ::: Results section...\n",
      "Extracting Overall conclusion section...\n",
      "Extracting Conclusion ::: Tacrolimus ::: Results section...\n",
      "Extracting Conclusion ::: JAK inhibitors ::: Results section...\n",
      "Extracting Conclusion ::: IL-1 blockade ::: Results section...\n",
      "Extracting Conclusion ::: TNFa blocker ::: Results section...\n",
      "Extracting Conclusion ::: All cytotoxic chemotherapy ::: Results section...\n",
      "Extracting DISCUSSION section...\n",
      "Extracting CONCLUSIONES section...\n",
      "Extracting OUTCOMES section...\n",
      "Extracting Personal protective equipment (PPE) preparation and outcome section...\n",
      "Extracting Overall clinical features and outcome section...\n",
      "Extracting Interpretation section...\n",
      "Extracting Interpretation: section...\n",
      "Extracting Discussion for neighboring nations section...\n",
      "Extracting Conclusion: section...\n",
      "Extracting Outcome section...\n",
      "Extracting Conclusions: section...\n",
      "Extracting Autres tumeurs et conclusions section...\n",
      "Extracting Added value of this study section...\n",
      "Extracting Research in context section...\n",
      "Extracting Postoperative outcomes section...\n",
      "Extracting Concluding Remarks section...\n",
      "Extracting Discussion 196 section...\n",
      "Extracting CONCLUSIONS section...\n",
      "Extracting V. Evaluation, Research and Dissemination for Impact and Outcomes section...\n",
      "Extracting Estimation of time intervals between symptom onset and outcome section...\n",
      "Extracting Conclusion 225 section...\n",
      "Extracting Outcomes section...\n",
      "Extracting Conclusion and future directions section...\n",
      "Extracting Conclusion 318 section...\n",
      "Extracting Conclusiones section...\n",
      "Extracting Discussion 270 section...\n",
      "Extracting Concluding Remarks and Future Perspectives section...\n",
      "Extracting Discussion 83 section...\n",
      "Extracting Conclusion 122 section...\n",
      "Extracting What Are the Outcomes If a Patient with IBD Develops COVID-19? section...\n",
      "Extracting Results and Discussion section...\n",
      "Extracting Conclusions - section...\n",
      "Extracting CONCLUSIONS AND RECOMMENDATIONS section...\n",
      "Extracting Outcome of the electronic search section...\n",
      "Extracting COVID-19 Outcomes and CVD: Potential Mechanisms of Increased Risk section...\n",
      "Extracting Conclusions and Future Directions section...\n",
      "Extracting Global conclusions section...\n",
      "Extracting Results and discussion section...\n",
      "Extracting Summary of findings section...\n",
      "Extracting Discussions section...\n",
      "Extracting Discussion and conclusions section...\n",
      "Extracting Image Interpretation ::: Materials and Method section...\n",
      "Extracting Definition of Clinical outcomes ::: Materials and Method section...\n",
      "Extracting Clinical outcomes ::: Results section...\n",
      "Extracting 5. Conclusions section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting 4.1.2. Serological Testing ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting 4.3. Therapeutics ::: 4. Discussion section...\n",
      "Extracting 4.2. Vaccines ::: 4. Discussion section...\n",
      "Extracting 4.1.1. Detection of Genetic Material ::: 4.1. Rapid Diagnostics ::: 4. Discussion section...\n",
      "Extracting Study records, data items and outcomes ::: Methods section...\n",
      "Extracting Discussion and conclusion section...\n",
      "Extracting Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design section...\n",
      "Extracting What is the clinical presentation and spectrum of disease? ::: DISCUSSION section...\n",
      "Extracting What treatments are effective (including the role of antivirals and steroids)? ::: DISCUSSION section...\n",
      "Extracting What are the psychosocial consequences of infection with the virus? ::: DISCUSSION section...\n",
      "Extracting Limitations ::: DISCUSSION section...\n",
      "Extracting What is the duration of viral shedding? ::: DISCUSSION section...\n",
      "Extracting What risk factors pre-dispose health care workers to infection or transmission? ::: DISCUSSION section...\n",
      "Extracting What is the optimal diagnostic test? ::: DISCUSSION section...\n",
      "Extracting What characteristics define a “case”? ::: DISCUSSION section...\n",
      "Extracting What are the risk factors for infection (in patient population)? ::: DISCUSSION section...\n",
      "Extracting What is the causative agent of disease? ::: DISCUSSION section...\n",
      "Extracting Implications for practice ::: DISCUSSION section...\n",
      "Extracting What are risk factors for death or severe illness? ::: DISCUSSION section...\n",
      "Extracting Outcomes ::: Results section...\n",
      "Extracting Conclusion and perspective section...\n",
      "Extracting Risk Factors of Mental Health Outcomes ::: Results section...\n",
      "Extracting Limitations ::: Discussion section...\n",
      "Extracting Outcomes and Covariates ::: Methods section...\n",
      "Extracting 4. Discussion section...\n",
      "Extracting 4. Discussion and Conclusions section...\n",
      "Extracting Discussion ::: Results section...\n",
      "Extracting Phylogenetic relationship among 2019-nCoV and other βCoVs ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf3b ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Orf8 ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Spike ::: Genome organization ::: Results and discussion section...\n",
      "Extracting RNA secondary structures ::: Genome organization ::: Results and discussion section...\n",
      "Extracting Demographics, comorbidities and outcomes section...\n",
      "Extracting 8. Discussion section...\n",
      "Extracting Clinical Outcomes ::: Results section...\n",
      "Extracting Study Outcomes ::: Methods section...\n",
      "Extracting Image interpretation section...\n",
      "Extracting Conclusions and future perspectives section...\n",
      "Extracting Conclusion and prospects section...\n",
      "Extracting Concluding remarks and future perspectives section...\n",
      "Extracting Imaging, complications, and outcomes section...\n",
      "Extracting Virology and pathogenesis ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Prevention and control ::: Research domains ::: Results and discussion section...\n",
      "Extracting Epidemiology ::: Research domains ::: Results and discussion section...\n",
      "Extracting Strengths and limitations of the study ::: Results and discussion section...\n",
      "Extracting Clinical manifestation and diagnosis ::: Research domains ::: Results and discussion section...\n",
      "Extracting Characteristics of published studies ::: Results and discussion section...\n",
      "Extracting Transmission pattern ::: Causes ::: Research domains ::: Results and discussion section...\n",
      "Extracting Complications, treatment and clinical outcomes during hospitalization and follow-up 296 section...\n",
      "Extracting Clinical outcomes section...\n",
      "Extracting Discussion. section...\n",
      "Extracting Genetic associations with outcome variables section...\n",
      "Extracting Concluding Thoughts section...\n",
      "Extracting Study outcomes section...\n",
      "Extracting Incidence and outcomes of patients with delayed-phase thrombocytopenia section...\n",
      "Extracting Research in context Evidence before this study section...\n",
      "Extracting CONCLUSIONS AND POTENTIAL RECOMMENDATIONS section...\n",
      "Extracting Conclusions and Future Work section...\n",
      "Extracting Conclusions and comments section...\n",
      "Extracting Conclusion & Future Directions 132 section...\n",
      "Extracting Outcomes: section...\n",
      "Extracting CONCLUSION AND DISCUSSION section...\n",
      "Extracting Conclusions 13 section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases section...\n",
      "Extracting Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase section...\n",
      "Extracting Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir. section...\n",
      "Extracting Summary and Conclusions section...\n",
      "Extracting Results and Discussions section...\n",
      "Extracting Conclusions and Resources section...\n",
      "Extracting The relationship between CT imaging and clinical outcome section...\n",
      "Extracting Conclusion and Discussion section...\n",
      "Extracting Clinical and Laboratory Data and Outcome Assessment section...\n",
      "Extracting IX. SUMMARY AND CONCLUSION section...\n",
      "Extracting Test Result Interpretation section...\n",
      "Extracting Primary Outcome section...\n",
      "Extracting Assessment and outcome section...\n",
      "Extracting Secondary Outcome section...\n",
      "Extracting Clinical outcomes of pregnant women with COVID-19 section...\n",
      "Extracting Case presentation and discussion section...\n",
      "Extracting Summary and Discussion section...\n",
      "Extracting Treatment and outcomes section...\n",
      "Extracting Secondary outcome，median(IQR) section...\n",
      "Extracting Primary and secondary outcomes in all patients section...\n",
      "Extracting Primary and secondary outcomes in subgroups section...\n",
      "Extracting Secondary outcome section...\n",
      "Extracting Discussion and Conclusion section...\n",
      "Extracting Pregnancy outcomes following delivery among COVID-19 infected women section...\n",
      "Extracting IV. DISCUSSION AND CONCLUSIONS section...\n",
      "Extracting Discussion of the main findings section...\n",
      "Extracting GRADE and 'Summary of findings' tables section...\n",
      "Extracting Interpretation of parameters section...\n",
      "Extracting Time intervals between symptom onset and outcome section...\n",
      "Extracting Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool section...\n",
      "Extracting Outcome definitions section...\n",
      "Extracting IV. Conclusion section...\n",
      "Extracting III. Discussion section...\n",
      "Extracting Neonatal outcomes section...\n",
      "Extracting Clinical characteristics and maternal outcomes section...\n",
      "Extracting Discussions and conclusions section...\n",
      "Extracting Critical Outcomes section...\n",
      "Extracting Other outcomes section...\n",
      "Extracting Discussions and Conclusion section...\n",
      "Extracting III. DISCUSSION section...\n",
      "Extracting Anxiety, behavioral outcomes and perceptions section...\n",
      "Extracting Discussion & Conclusions section...\n",
      "Extracting CONCLUSIONS: section...\n",
      "Extracting Exposures, outcomes and confounders section...\n",
      "Extracting Outcome Data section...\n",
      "Extracting Conclusion. section...\n",
      "Extracting STUDY OUTCOMES section...\n",
      "Extracting NEONATAL OUTCOMES section...\n",
      "Extracting MATERNAL OUTCOMES section...\n",
      "Extracting DISCUSSION Rigorous evaluation of Traditional Chinese Medicine as an epidemic response section...\n",
      "Extracting Discussion 177 section...\n",
      "Extracting AGI grades and clinical outcomes section...\n",
      "Extracting Conclusions: 61 section...\n",
      "Extracting V. Conclusions section...\n",
      "Extracting III. Results and Model Interpretation section...\n",
      "Extracting III. RESULTS AND DISCUSSIONS section...\n",
      "Extracting Summary and conclusions section...\n",
      "Extracting Outcome parameters section...\n",
      "Extracting VI. DISCUSSION section...\n",
      "Extracting Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO section...\n",
      "Extracting Experimental Results and Discussion section...\n",
      "Extracting Conclusion and future work section...\n",
      "Extracting IMAGINE INTERPRETATION section...\n",
      "Extracting Conclusions and future directions section...\n",
      "Extracting IV. DISCUSSION section...\n",
      "Extracting Clinical outcome section...\n",
      "Extracting Discussion and Conclusion 185 section...\n",
      "Extracting CONCLUSION AND FUTURE WORK section...\n",
      "Extracting Non-specific amplification does not affect outcome of US CDC assay section...\n",
      "Extracting Conclusion and policy implication section...\n",
      "Extracting A.2 Interpretation section...\n",
      "Extracting 3) Discussion section...\n",
      "Extracting Discussion and Conclusions section...\n",
      "Extracting Presence of comorbidities and the clinical characteristics and outcomes of COVID-19 section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities section...\n",
      "Extracting DISCUSSION AND LIMITATION section...\n",
      "Extracting Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates section...\n",
      "Extracting Results and discussions section...\n",
      "Extracting Forecast and Discussion section...\n",
      "Extracting Disease process and clinical outcomes section...\n",
      "Extracting Main outcomes section...\n",
      "Extracting Conclusions and Future directions section...\n",
      "Extracting Outcome Measures and Definitions section...\n",
      "Extracting Outcome of patients treated with CP as compared to a recent historic control groupAhistoric section...\n",
      "Extracting Research in Context section...\n",
      "Extracting Clinical Outcomes section...\n",
      "Extracting Figure 3. Predicting positive testing outcome windows for diagnosed patients section...\n",
      "Extracting Safety outcomes section...\n",
      "Extracting Efficacy outcomes section...\n",
      "Extracting VI. Conclusions VI. Conclusions section...\n",
      "Extracting Treatment Situation and In-hospital Outcomes section...\n",
      "Extracting DISCUSSION: section...\n",
      "Extracting VII. CONCLUSIONS section...\n",
      "Extracting FITTING RESULTS & INTERPRETATIONS section...\n",
      "Extracting DISCUSSION & CONCLUSION section...\n",
      "Extracting Primary outcome section...\n",
      "Extracting Discussion 114 section...\n",
      "Extracting Maternal outcomes section...\n",
      "Extracting Outcomes 268 section...\n",
      "Extracting DISCUSSIONS section...\n",
      "Extracting Outcome scoring section...\n",
      "Extracting Outcomes pool section...\n",
      "Extracting Timeline and outcome of the disease progression 219 section...\n",
      "Extracting Conclusion 353 section...\n",
      "Extracting On the Interpretation of PIPE-Sites Predictions section...\n",
      "Extracting Results & Discussion section...\n",
      "Extracting Conclusions and implications section...\n",
      "Extracting Discussion 226 section...\n",
      "Extracting Discussion and conclusions. section...\n",
      "Extracting Discussions and conclusion section...\n",
      "Extracting Graph interpretation section...\n",
      "Extracting Discussion and recommendations for future: section...\n",
      "Extracting III. DISCUSSION AND SUMMARY section...\n",
      "Extracting Interpretation (1,026 words) section...\n",
      "Extracting RESULTS & DISCUSSION section...\n",
      "Extracting Type of outcomes section...\n",
      "Extracting Conclusion and Relevance section...\n",
      "Extracting RESEARCH IN CONTEXT section...\n",
      "Extracting Main Interventions and Outcomes section...\n",
      "Extracting LYM% indicates the outcome of COVID-19 patients section...\n",
      "Extracting Findings and Discussion section...\n",
      "Extracting Limitations and conclusions section...\n",
      "Extracting IV. CONCLUSION section...\n",
      "Extracting III. RESULTS AND DISCUSSION section...\n",
      "Extracting Predicted outcomes by Region section...\n",
      "Extracting Conclusions and perspective. section...\n",
      "Extracting Discussion 191 section...\n",
      "Extracting Efficacy until Day 6 outcomes section...\n",
      "Extracting Conclusions and recommendations section...\n",
      "Extracting V. DISCUSSION AND CONCLUSION section...\n",
      "Extracting Study Definitions and Outcomes section...\n",
      "Extracting Conclusions and policy implications section...\n",
      "Extracting Summary of policy measures on key outcome measures section...\n",
      "Extracting Main management strategies, comorbid conditions, and clinical outcome data section...\n",
      "Extracting Conclusion and recommendations section...\n",
      "Extracting CONCLUSION: section...\n",
      "Extracting Other Outcomes section...\n",
      "Extracting V. DISCUSSION section...\n",
      "Extracting Conclusions. section...\n",
      "Extracting Conclusion and Future Research Directions section...\n",
      "Extracting Correlation Analysis between Cytokines related to Immunity and Inflammation and E2 or COVID-19' Severity/Outcomes section...\n",
      "Extracting Inflammation and poor clinical outcomes section...\n",
      "Extracting Independent predictors for adverse clinical outcome section...\n",
      "Extracting A. Interpretation of the public data section...\n",
      "Extracting Interpretation and implications section...\n",
      "Extracting Discussion 233 section...\n",
      "Extracting Conclusions 266 section...\n",
      "Extracting Outcome data section...\n",
      "Extracting Outcomes and risk factors for longer hospitalization of COVID-19 section...\n",
      "Extracting Discussion 193 section...\n",
      "Extracting Estimation Results and Discussion section...\n",
      "Extracting Discussion 224 section...\n",
      "Extracting Endpoint outcome assessment section...\n",
      "Extracting Conclusions and Discussion section...\n",
      "Extracting Conclusions 345 section...\n",
      "Extracting Conclusions and further directions section...\n",
      "Extracting Treatment and clinical outcome section...\n",
      "Extracting Concluding remarks: from focusing on pathogens to understanding virus species section...\n",
      "Extracting Final Concluding Remarks based on our COVID-19 Predictions in China section...\n",
      "Extracting Conclusion B: section...\n",
      "Extracting Conclusion A: section...\n",
      "Extracting Conclusions on the reproductive number section...\n",
      "Extracting d. Conclusions section...\n",
      "Extracting IV -Discussion section...\n",
      "Extracting Clinical Outcomes, Complications and Treatment section...\n",
      "Extracting V. CONCLUSION AND DISCUSSION section...\n",
      "Extracting Limitations and conclusion section...\n",
      "Extracting Discussion 163 section...\n",
      "Extracting RECOMMENDATIONS AND CONCLUSION section...\n",
      "Extracting Discussion 230 section...\n",
      "Extracting III. CONCLUSIONS section...\n",
      "Extracting Discussion: Implications for COVID-19 section...\n",
      "Extracting Conclusion: 217 section...\n",
      "Extracting Patient follow-up and clinical outcomes section...\n",
      "Extracting Follow-up and outcomes section...\n",
      "Extracting Discussion and Policy Recommendations section...\n",
      "Extracting Conclusions and Recommendations section...\n",
      "Extracting Interpretation and Concluding Remarks section...\n",
      "Extracting Discussion and possible extensions section...\n",
      "Extracting VI. Discussion section...\n",
      "Extracting Discussion 173 section...\n",
      "Extracting Interpretation of RT-LAMP results section...\n",
      "Extracting Perinatal outcomes Delivery characteristics section...\n",
      "Extracting Predictors and Outcomes section...\n",
      "Extracting Additional information on our results and discussion section...\n",
      "Extracting Discussion of global prospects section...\n",
      "Extracting The outcome of the treatment section...\n",
      "Extracting V. CONCLUSION section...\n",
      "Extracting IV. DISCUSSIONS section...\n",
      "Extracting Risk factors associated with clinical outcomes and survival analysis section...\n",
      "Extracting DISCUSSION 237 section...\n",
      "Extracting Outcome measures and statistical analysis section...\n",
      "Extracting Results and Conclusions section...\n",
      "Extracting DISCUSSION 272 section...\n",
      "Extracting IV. DISCUSSION AND SUMMARY section...\n",
      "Extracting III. RESULTS AND CONCLUSION section...\n",
      "Extracting Conclusion 211 section...\n",
      "Extracting DISCUSSION AND PERSPECTIVES section...\n",
      "Extracting III. REINTERPRETATION AND RESULTS section...\n",
      "Extracting Conclusions 80 section...\n",
      "Extracting Model Interpretation and Visualization section...\n",
      "Extracting Composition of Garlic Essential Oil ::: Results and Discussion section...\n",
      "Extracting Docking Results of Compounds in Garlic Essential Oil into the PDB6LU7 Protein of SARS-CoV-2 ::: Docking Simulation ::: Results and Discussion section...\n",
      "Extracting Outcome Measures ::: Methods section...\n",
      "Extracting Secondary Outcomes ::: Results section...\n",
      "Extracting Primary Outcome ::: Results section...\n",
      "Extracting Adjusting for outcome delay in case fatality ratio estimates section...\n",
      "Extracting Achievements and challenges ::: Discussion section...\n",
      "Extracting Conclusion and policy implications ::: Discussion section...\n",
      "Extracting Strengths and limitations of this study ::: Discussion section...\n",
      "Extracting Conclusions and Outlook section...\n",
      "Extracting Clinical course and outcomes ::: RESULTS section...\n",
      "Extracting Quarantine in the wider context ::: Discussion section...\n",
      "Extracting The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS section...\n",
      "Extracting 4. Conclusions section...\n",
      "Extracting 3.5. DNA Amplification ::: 3. Results and Discussion section...\n",
      "Extracting 3.3. Metal Adhesion ::: 3. Results and Discussion section...\n",
      "Extracting Milling and Optical Transparency ::: 3.2. Fabrication ::: 3. Results and Discussion section...\n",
      "Extracting 3.1. COMSOL MultiPhysics Simulation Results ::: 3. Results and Discussion section...\n",
      "Extracting 3.4. Chip Functioning ::: 3. Results and Discussion section...\n",
      "Extracting Outcomes ::: Methods section...\n",
      "Extracting General clinical characteristics and outcomes of Chinese patients with COVID-19 section...\n",
      "Extracting Treatment and outcomes of the study population section...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting 3 Discussion and conclusion section...\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "Extract sections from covid-19 papers, using the 242 headers extracted by regex pattern.\n",
    "\n",
    "\"\"\"\n",
    "\n",
    "sect_dict = extract_sections_from_pq_files_by_uid(pq_files, covid19_uid_list, ext_header_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 308,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "Add the extracted section headers/text for covid-19 papers to the covid19_title_abstract_dict.\n",
    "\n",
    "\"\"\"\n",
    "\n",
    "sect_header_uids = set([])\n",
    "\n",
    "uid_headers_and_text_dict = {}\n",
    "\n",
    "for sect_header, uid_texts in sect_dict.items():\n",
    "    \n",
    "    for uid, text in uid_texts.items():\n",
    "        covid19_title_abstract_dict[uid][sect_header] = ' '.join(text)\n",
    "for uid, sect_header_text in  covid19_title_abstract_dict.items():\n",
    "    if uid not in uid_headers_and_text_dict:\n",
    "        uid_headers_and_text_dict[uid] = {}\n",
    "    uid_headers_and_text_dict[uid]['text'] = sect_header_text\n",
    "    uid_section_headers = uid_section_headers_dict.get(uid, {'title', 'abstract'})\n",
    "    uid_headers_and_text_dict[uid]['available_headers'] = list(uid_section_headers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 309,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "Write dict to json\n",
    "\n",
    "\"\"\"\n",
    "\n",
    "with open('uids_section_header_and_texts_dict_200427.json', 'w') as f:\n",
    "    json.dump(uid_headers_and_text_dict, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'uid_headers_and_text_dict' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-3-8db8a5199005>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0;32mfor\u001b[0m \u001b[0muid\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mheaders_text\u001b[0m \u001b[0;32min\u001b[0m \u001b[0muid_headers_and_text_dict\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mitems\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mheader\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtext\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mheaders_text\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'text'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mitems\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m         \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0muid\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mheader\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlen\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtext\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'uid_headers_and_text_dict' is not defined"
     ]
    }
   ],
   "source": [
    "for uid, headers_text in uid_headers_and_text_dict.items():\n",
    "    for header, text in headers_text['text'].items():\n",
    "        print(uid, header, len(text))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 316,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(iii) What comorbidities are associated with severe disease outcome and how do these affect viral pathogenesis? ::: \n",
      "Adjusting for outcome delay in case fatality ratio estimates\n",
      "Clinical course and outcomes ::: RESULTS\n",
      "General clinical characteristics and outcomes of Chinese patients with COVID-19\n",
      "The efficacy outcome ::: MSC treatment procedure and general patient information ::: RESULTS\n",
      "The primary safety outcome ::: MSC treatment procedure and general patient information ::: RESULTS\n",
      "Type of outcome measurements ::: Inclusion criteria ::: Eligibility criteria ::: Methods/design\n",
      "Study records, data items and outcomes ::: Methods\n",
      "Definition of Clinical outcomes ::: Materials and Method\n",
      "Clinical outcomes ::: Results\n",
      "Imaging, complications, and outcomes\n",
      "Postoperative outcomes\n",
      "Personal protective equipment (PPE) preparation and outcome\n",
      "Overall clinical features and outcome\n",
      "Complications, treatment and clinical outcomes during hospitalization and follow-up 296\n",
      "The relationship between CT imaging and clinical outcome\n",
      "Clinical outcomes\n",
      "Estimation of time intervals between symptom onset and outcome\n",
      "Endpoint outcome assessment\n",
      "Perinatal outcomes Delivery characteristics\n",
      "Anxiety, behavioral outcomes and perceptions\n",
      "Timeline and outcome of the disease progression 219\n",
      "Primary outcome of mortality\n",
      "Secondary outcomes Antibody Levels\n",
      "Treatment and clinical outcome\n",
      "Presence of comorbidities and the clinical characteristics and outcomes of COVID-19\n",
      "Clinical characteristics and outcomes of COVID-19 stratified by the number of comorbidities\n",
      "LYM% indicates the outcome of COVID-19 patients\n",
      "Clinical outcomes\n",
      "Main management strategies, comorbid conditions, and clinical outcome data\n",
      "Time intervals between symptom onset and outcome\n",
      "Neonatal outcomes\n",
      "Clinical characteristics and maternal outcomes\n",
      "Study outcomes\n",
      "Predicted outcomes by Region\n",
      "Safety outcomes\n",
      "Efficacy outcomes\n",
      "Independent predictors for adverse clinical outcome\n",
      "Primary outcome\n",
      "Secondary outcome\n",
      "Patient follow-up and clinical outcomes\n",
      "Follow-up and outcomes\n",
      "Clinical outcome\n",
      "Maternal outcomes\n",
      "Neonatal outcomes\n",
      "Clinical outcomes\n",
      "Risk factors associated with clinical outcomes and survival analysis\n",
      "Disease process and clinical outcomes\n",
      "AGI grades and clinical outcomes\n",
      "Figure 3. Predicting positive testing outcome windows for diagnosed patients\n",
      "Treatment and outcomes\n",
      "Non-specific amplification does not affect outcome of US CDC assay\n",
      "Pregnancy outcomes following delivery among COVID-19 infected women\n",
      "Inflammation and poor clinical outcomes\n",
      "The outcome of the treatment\n",
      "Type of outcomes\n",
      "Assessment of Exposure, Ascertainment of outcomes, Ascertainment of covariates\n",
      "Summary of policy measures on key outcome measures\n",
      "Other outcomes\n",
      "Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool\n",
      "Efficacy until Day 6 outcomes\n",
      "Safety outcomes\n",
      "Exposures, outcomes and confounders\n",
      "Type of outcomes\n",
      "Main outcomes\n",
      "Table 6: Summary of chi-squared tests for association between blood type and COVID-19 outcomes. Counts for groups 1 and 2 are the individual group counts for the former and latter groups in the comparison. For example, in the 'COV+ vs COV-' comparison, Group 1 counts gives counts and percentages for 'COV+' and Group 2 counts gives counts for 'COV-'. ABO\n",
      "Genetic associations with outcome variables\n",
      "Treatment and outcomes\n",
      "Assessment and outcome\n",
      "Projections of SARS CoV-2 outcomes assuming remdesivir treatment during early and late symptomatic phases\n",
      "Projections of SARS CoV-2 outcomes assuming extremely early remdesivir treatment during the pre-symptomatic phase\n",
      "Figure 5. Predictors of SARS CoV-2 treatment outcomes with remdesivir.\n",
      "Study outcomes\n",
      "Incidence and outcomes of patients with delayed-phase thrombocytopenia\n",
      "Secondary outcome，median(IQR)\n",
      "Primary and secondary outcomes in all patients\n",
      "Primary and secondary outcomes in subgroups\n",
      "Secondary outcome\n",
      "Demographics, comorbidities and outcomes\n",
      "Treatment and outcomes of the study population\n",
      "Clinical outcomes of pregnant women with COVID-19\n",
      "Clinical features and outcomes of the patients\n"
     ]
    }
   ],
   "source": [
    "\n",
    "with open(\"covid_vt_contra_outcome_text_examples.txt\", 'w') as f:\n",
    "    for uid, header_text in uid_headers_and_text_dict.items():\n",
    "        if 'Outcomes' in (header_text['available_headers']):\n",
    "            f.write('%s\\n' % uid)\n",
    "            f.write('%s\\n' % header_text['text']['Outcomes'])\n",
    "            f.write(\"\\n\")\n",
    "            \n",
    "        for header in header_text['available_headers']:\n",
    "            if 'outcome' in header:\n",
    "                print(header)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "merge"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
